Extrapyramidal and movement disorders

G6_XTRAPYR

basal ganglia disease: A disease involving the basal ganglia.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G20-G26 Cause of death: ICD-10 — G20-G26 2 out of 7 registries used, show all original rules.	14711
4. Check minimum number of events None	14711
5. Include endpoints G6_PARKINSON G6_PARKSCND G6_BASDEGENOTH G6_DYSTON G6_XTRAPYROTH	18528
6. Filter based on genotype QC (FinnGen only)	18016

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	G6_XTRAPYR
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_PARKINSON\|G6_PARKSCND\|G6_BASDEGENOTH\|G6_DYSTON\|G6_XTRAPYROTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G2
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G2
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Extrapyramidal and movement disorders based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	134703	69914	63238
Only index persons	105762	56932	48830
Unadjusted period prevalence (%)
Whole population	1.89	2.00	1.77
Only index persons	1.99	2.09	1.86
Median age at first event (years)
Whole population	67.76	67.76	67.69
Only index persons	66.50	66.48	66.53

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	18016	9869	8147
Unadjusted period prevalence (%)	3.61	3.50	3.73
Median age at first event (years)	64.79	62.44	67.64

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
18526: Matched controls
185256

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N05AN01

ATC

lithium; oral

5.2

322.4

678

1341

N06AB10

ATC

escitalopram; oral

2.1

319.3

3811

20429

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.9

316.5

1577

5687

L28

ICPC

Limited function/disability (L)

2.0

310.5

4047

22378

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.4

310.4

2439

11017

N05AH04

ATC

quetiapine; oral

3.5

307.7

4857

16919

N05AH03

ATC

olanzapine; systemic

4.1

307.7

1692

4418

N87

ICPC

Parkinsonism

155.7

307.7

2051

148

G25.3

ICD-10 Finland

Myoclonus

196.6

307.7

233

AA1AD

NOMESCO Finland

CT of head and brain

2.0

307.7

6086

36540

N03AX16

ATC

[U] pregabalin

2.0

307.7

5001

28655

N04BD02

ATC

rasagiline; oral

1711.4

307.7

1094

G24.5

ICD-10 Finland

Blepharospasm

298.1

307.7

351

N06AX11

ATC

mirtazapine; oral

2.2

307.7

7377

42968

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

28.3

307.7

257

G04BD12

ATC

mirabegron; oral

2.3

307.7

2944

13789

N06AX16

ATC

venlafaxine; oral

2.5

307.7

2917

13080

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

3097.4

307.7

1482

193

Kela drug reimbursment

Rasagiline

+∞

307.7

828

N06DA03

ATC

rivastigmine; oral, transdermal

4.1

307.7

1528

3944

N04BB01

ATC

amantadine; oral

6.3

307.7

561

916

N05AA02

ATC

levomepromazine; systemic

3.9

307.7

1087

2902

N04AA02

ATC

biperiden; systemic

13.9

307.7

1103

842

N04BC09

ATC

rotigotine; transdermal

264.4

307.7

564

N04BC04

ATC

ropinirole; oral

165.3

307.7

1546

102

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

+∞

307.7

5437

N06AB04

ATC

citalopram; systemic

2.1

307.7

4444

24247

N06AX21

ATC

duloxetine; oral

2.5

307.7

2624

11328

AAG20

NOMESCO Finland

Stereotactic intracranial implantation of electrodes

577.1

307.7

341

3AX01, ,

NOMESCO Finland

38.9

307.7

336

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

66.3

307.7

345

G24.3

ICD-10 Finland

Spasmodic torticollis

111.2

307.7

1245

120

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

192.1

307.7

1534

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

409.8

307.7

401

G25.1

ICD-10 Finland

Drug-induced tremor

138.8

307.7

260

C07AA05

ATC

propranolol; systemic

3.8

307.7

5886

20445

N03AG01

ATC

valproic acid; systemic, rectal

3.6

307.7

1608

4704

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

450.1

307.7

355

N04

ICPC

Restless legs

15.9

307.7

343

219

N04BC05

ATC

pramipexole; oral

17.3

307.7

6494

5591

R25.1

ICD-10 Finland

Tremor, unspecified

20.6

307.7

2702

1523

N05BA04

ATC

oxazepam; oral

2.2

307.7

5824

31605

G25.0

ICD-10 Finland

Essential tremor

57.7

307.7

3420

724

G25.2

ICD-10 Finland

Other specified forms of tremor

59.3

307.7

658

115

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.1

307.7

2247

8001

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

+∞

307.7

5708

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

8301.7

307.7

805

R53

ICD-10 Finland

Malaise and fatigue

2.2

307.7

5380

29215

G20

ICD-10 Finland

Parkinson disease

756.5

307.7

5852

113

N04BX02

ATC

entacapone; oral

2444.4

307.7

496

G24.9

ICD-10 Finland

Dystonia, unspecified

277.0

307.7

564

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.9

307.7

2029

5697

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

137.1

307.7

6062

655

N02BF01

ATC

gabapentin; oral

2.9

307.7

2056

7683

N05AX12

ATC

aripiprazole; systemic

4.7

307.7

917

2031

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.3

307.7

2386

8011

N03AE01

ATC

clonazepam; systemic

8.6

307.7

3124

4260

N03AA03

ATC

primidone; oral

60.8

307.7

240

G24.8

ICD-10 Finland

Other dystonia

395.7

307.7

463

N03AX12

ATC

[U] gabapentin; oral

2.8

307.7

4298

18147

N04BD01

ATC

selegiline; oral

246.6

307.7

2158

N05BA01

ATC

diazepam; systemic, rectal

2.2

306.0

2880

14045

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

+∞

303.9

291

N05AX08

ATC

risperidone; systemic

2.6

297.8

1985

8303

N05AH02

ATC

clozapine; systemic

6.5

291.0

484

766

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

275.4

3216

17002

N05AF03

ATC

chlorprothixene; systemic

4.5

275.2

683

1550

G24

ICD-10 Finland

Dystonia

107.7

270.6

139

N03AX09

ATC

lamotrigine; oral

3.4

270.3

1015

3090

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.6

265.0

1697

6946

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.2

254.3

532

1046

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

36.0

251.6

157

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

4.4

251.2

647

1511

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.5

250.6

1737

7375

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

13.3

249.8

237

181

ZX114

NOMESCO Finland

Intramuscular

5.6

246.0

470

851

N05BA06

ATC

lorazepam; systemic, sublingual

2.8

243.2

1268

4667

A28

ICPC

Limited function/disability NOS

1.9

242.9

3796

22104

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.5

238.9

597

1361

N04BX04

ATC

opicapone; oral

2219.8

236.7

229

N29

ICPC

Neurological sympt/complt other

4.5

232.4

584

1337

A06AD11

ATC

lactulose; oral

1.9

226.8

3243

18291

M54.5

ICD-10 Finland

Low back pain

1.7

226.3

6431

44431

F51.0

ICD-10 Finland

Nonorganic insomnia

2.0

221.2

2766

14886

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

219.6

5602

37538

N05CF01

ATC

zopiclone; oral

1.7

219.1

6359

44083

H02AA02

ATC

fludrocortisone; oral

7.3

218.2

322

448

R42

ICD-10 Finland

Dizziness and giddiness

1.8

217.9

4681

29894

XA800

NOMESCO Finland

Neuropsychological investigation

3.1

215.4

923

3039

N05AB03

ATC

perphenazine; systemic, rectal

3.3

207.7

797

2454

N06AB06

ATC

sertraline; oral

2.2

205.7

2039

10046

G23.1

ICD-10 Finland

Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]

1914.1

205.4

199

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

205.0

3734

22664

N03AX11

ATC

topiramate; oral

4.2

202.1

549

1334

M03BX01

ATC

baclofen; systemic

4.4

200.9

508

1168

M79.6

ICD-10 Finland

Pain in limb

1.6

199.8

7538

55444

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.9

199.8

451

946

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.1

197.0

2141

10917

I95.1

ICD-10 Finland

Orthostatic hypotension

2.9

196.4

997

3609

N02BF02

ATC

pregabalin; oral

2.6

192.8

1234

5025

N05CD07

ATC

temazepam; oral

2.0

191.8

2548

13949

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

190.8

6003

42124

N06AX26

ATC

vortioxetine; oral

2.5

190.7

1304

5478

N08

ICPC

Abnormal involuntary movements

16.2

190.1

161

100

A04

ICPC

Weakness/tiredness general

1.9

189.2

2897

16616

SPAT1229

SPAT

Assessment of need for aid

2.2

185.6

1762

8518

G47.3

ICD-10 Finland

Sleep apnoea

1.7

185.1

4047

25792

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.3

181.6

1486

6757

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.6

180.6

435

962

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.0

180.1

2047

10591

G21.8

ICD-10 Finland

Other secondary parkinsonism

362.9

179.8

181

P72

ICPC

Schizophrenia

4.7

178.3

424

928

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

178.2

5002

33997

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.8

178.1

407

862

N06AX12

ATC

bupropion; oral

2.6

177.9

1133

4598

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.4

177.4

662

2001

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.9

176.9

856

3016

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

1809.8

176.2

171

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

173.7

1169

4869

SPAT1216

SPAT

Assessment of functional ability

1.8

171.8

3229

19662

N05AA01

ATC

chlorpromazine; systemic, rectal

5.3

170.4

346

662

N28

ICPC

Limited function/disability (N)

4.1

169.0

472

1170

L03

ICPC

Low back symptom/complaint

1.6

169.0

4855

33108

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

6.1

167.7

291

480

N99

ICPC

Neurological disease other

4.9

165.1

370

771

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.5

164.4

1058

4312

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

162.7

1881

9774

SPAT1240

SPAT

Therapeutic discussion

2.1

161.6

1687

8441

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.7

161.3

929

3585

N06AB03

ATC

fluoxetine; oral

1.9

160.4

2230

12344

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

160.1

3219

19942

XF606

NOMESCO Finland

Ortostatic test

6.3

154.1

260

417

N02BE01

ATC

paracetamol; systemic, rectal

1.8

152.3

16149

146365

G51.3

ICD-10 Finland

Clonic hemifacial spasm

12.5

152.0

149

120

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.2

151.7

1466

7114

R06.0

ICD-10 Finland

Dyspnoea

1.6

151.5

5017

35227

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

7.7

150.5

211

277

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

150.2

1326

6207

N06AX03

ATC

mianserin; oral

2.5

149.9

1011

4209

N05AC02

ATC

thioridazine; oral

3.9

149.8

448

1167

N05BA12

ATC

alprazolam; oral

2.0

149.6

1870

9972

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

8.3

148.9

195

236

N06AA09

ATC

amitriptyline; systemic

2.0

147.5

1908

10293

R1250

NOMESCO Finland

Evaluation of functional capability

3.5

147.4

522

1525

N05AF05

ATC

zuclopenthixol; systemic

5.9

146.7

266

458

R4130

NOMESCO Finland

Speech therapy

3.3

146.7

584

1836

P29

ICPC

Psychological sympt/compl other

2.4

146.5

1076

4655

L17

ICPC

Foot/toe symptom/complaint

1.6

146.2

5155

36663

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

5.0

146.1

316

639

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

144.8

6239

46340

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.8

144.5

773

2870

N05AD01

ATC

haloperidol; systemic

2.9

144.1

710

2523

F02.39

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

708.9

143.1

141

M48.0

ICD-10 Finland

Spinal stenosis

1.8

142.5

2503

14866

P03

ICPC

Feeling depressed

2.1

139.3

1458

7287

TAB00

NOMESCO Finland

Lumbar puncture

2.6

138.5

849

3375

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

135.5

2942

18527

R35

ICD-10 Finland

Polyuria

2.1

134.5

1388

6896

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.2

134.5

1283

6185

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

134.5

1389

6903

R51.80

ICD-10 Finland

Headache

1.8

134.3

2530

15316

N04BC06

ATC

cabergoline; oral

8.4

134.0

175

211

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

5.0

134.0

288

579

P76

ICPC

Depressive disorder

2.3

133.9

1026

4519

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.8

133.9

714

2646

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

133.7

2972

18828

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

35.2

133.6

N30.0

ICD-10 Finland

Acute cystitis

1.7

133.4

2965

18781

P99

ICPC

Psychological disorders other

3.3

132.4

519

1616

R13

ICD-10 Finland

Dysphagia

2.1

132.0

1394

6986

SPAT1234

SPAT

Support of social functional capacity

2.2

131.4

1121

5166

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.5

129.0

847

3478

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

128.7

1836

10206

P01

ICPC

Feeling anxious/nervous/tense

2.0

127.9

1587

8421

N05CF02

ATC

zolpidem; oral

1.7

126.5

2961

18987

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

125.8

3007

19383

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.2

124.0

496

1563

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

123.5

3985

27598

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.3

122.4

464

1415

G44.2

ICD-10 Finland

Tension-type headache

1.8

122.3

2271

13663

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

3.4

122.3

446

1327

3320A

ICD-9 Finland

Parkinson's disease, Paralysis agitans

+∞

122.0

117

R25.8

ICD-10 Finland

Other and unspecified abnormal involuntary movements

10.5

121.6

134

129

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

121.0

4715

34006

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.5

120.2

761

3070

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

119.9

5278

39024

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

119.5

5072

37216

G23.8

ICD-10 Finland

Other specified degenerative diseases of basal ganglia

307.1

119.3

121

L01

ICPC

Neck symptom/complaint

1.7

119.1

2614

16457

P20

ICPC

Memory disturbance

1.7

118.9

2736

17438

M03BX02

ATC

tizanidine; oral

1.4

118.9

10165

85081

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.4

118.8

433

1288

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.9

118.6

571

2002

N04AA01

ATC

trihexyphenidyl; oral

41.9

118.1

M03AX01

ATC

botulinum toxin; parenteral

4.9

117.6

258

528

G24.0

ICD-10 Finland

Drug-induced dystonia

390.0

116.7

117

N06AB05

ATC

paroxetine; oral

2.2

116.4

1037

4860

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.3

115.6

448

1385

Z2445

NOMESCO Finland

Psychologist

2.7

115.2

645

2449

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.9

115.2

340

877

N06AX22

ATC

agomelatine; oral

3.5

114.7

411

1209

AA400

NOMESCO Finland

Electroconvulsive therapy

5.8

114.5

208

359

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.5

114.2

751

3084

G90.3

ICD-10 Finland

Multi-system degeneration

34.4

113.8

29580

ICD-8 Finland

Schizophrenia, Other

7.7

113.8

159

208

K59.0

ICD-10 Finland

Constipation

2.1

112.9

1134

5567

G25

ICD-10 Finland

Other extrapyramidal and movement disorders

17.6

111.9

P06

ICPC

Sleep disturbance

1.8

111.1

1897

11120

N05BE01

ATC

buspirone; oral

2.8

110.6

570

2073

N04BC02

ATC

pergolide; oral

166.7

110.4

116

A02BC02

ATC

pantoprazole; systemic

1.4

109.7

12003

104243

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

5.3

109.7

221

420

A02BC05

ATC

esomeprazole; systemic

1.4

107.8

7005

55474

N02AX02

ATC

tramadol; systemic, rectal

1.4

107.8

7530

60401

SPAT1301

SPAT

No procedures

1.5

107.3

5548

42131

N06AX05

ATC

trazodone; oral

3.0

107.3

495

1695

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.8

106.9

571

2116

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

4.5

106.8

260

580

R49.02

ICD-10 Finland

Spasmodic dysphonia

13.2

105.6

100

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

105.3

3524

24483

188

Kela drug reimbursment

Psychosis requiring demanding treatment

5.1

105.0

223

444

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.4

105.0

392

1184

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.2

104.3

281

678

R60.0

ICD-10 Finland

Localized oedema

1.7

103.8

2306

14522

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

103.6

7575

61107

D21

ICPC

Swallowing problem

3.5

103.1

359

1037

U04

ICPC

Incontinence urine

2.1

102.1

1079

5394

SPAT1254

SPAT

Administration of medicine

1.6

102.0

2708

17828

A01

ICPC

Pain general/multiple sites

1.8

101.8

1652

9527

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.6

101.5

347

990

R52.9

ICD-10 Finland

Pain, unspecified

1.8

100.7

1719

10060

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.3

98.0

253

591

R5110, ,

SPAT

1.9

97.6

1266

6797

N19

ICPC

Speech disorder

3.7

97.3

309

839

K02.1

ICD-10 Finland

Caries of dentine

1.4

97.2

9194

77117

N06AG02

ATC

moclobemide; oral

2.2

95.8

806

3685

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.8

95.7

301

812

ZY010

NOMESCO Finland

Hospital outpatient

2.3

95.0

785

3563

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

94.8

1975

12209

R03AC02

ATC

salbutamol; inhalant

1.4

94.7

9038

75786

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

3.7

94.5

309

856

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.9

94.4

1216

6512

F31

ICD-10 Finland

Bipolar affective disorder

4.3

94.0

242

564

R55

ICD-10 Finland

Syncope and collapse

1.7

93.5

2066

12969

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

93.4

11521

100584

S06.0

ICD-10 Finland

Concussion

1.7

93.2

1810

10978

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.8

92.2

287

769

SPAT1053

SPAT

Memory test

1.6

91.6

2846

19385

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

5.0

91.6

196

393

DQD34

NOMESCO Finland

Treatment of spasmodic dysfonia

20.1

91.4

F34.1

ICD-10 Finland

Dysthymia

2.5

90.8

590

2408

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

6.0

90.8

159

265

M79.1

ICD-10 Finland

Myalgia

1.6

90.7

2272

14712

N06AA06

ATC

trimipramine; systemic

2.8

90.6

469

1709

J01EA01

ATC

trimethoprim; systemic

1.4

90.5

4476

33492

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.9

90.3

270

703

N17

ICPC

Vertigo/dizziness

1.6

89.7

2169

13922

A02BC03

ATC

lansoprazole; oral

1.4

89.2

4964

37929

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

87.9

6786

54773

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

87.8

1720

10447

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.2

87.5

354

1123

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

87.0

991

5084

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

86.9

2816

19338

N03AF01

ATC

carbamazepine; oral, rectal

2.1

86.5

915

4571

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

86.1

2332

15374

M79.7

ICD-10 Finland

Fibromyalgia

2.4

86.0

594

2493

A02BC01

ATC

omeprazole; systemic

1.4

85.8

4738

36105

29599

ICD-8 Finland

Schizophrenia, Unspecified type

6.2

85.1

145

235

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

84.7

2250

14759

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.0

84.5

929

4706

M25.5

ICD-10 Finland

Pain in joint

1.4

84.5

4965

38232

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.9

84.3

404

1413

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

84.1

1341

7674

R47.1

ICD-10 Finland

Dysarthria and anarthria

4.1

84.1

232

570

F32.1

ICD-10 Finland

Moderate depressive episode

2.1

84.0

794

3801

XKD00

NOMESCO Finland

Uroflowmetry

1.5

84.0

2865

19879

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.6

83.8

516

2052

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

4.6

83.6

198

432

R4110, ,

SPAT

1.8

83.6

1494

8840

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.9

83.2

1149

6289

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.2

82.6

325

1014

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

4.2

82.6

222

535

F02.30

ICD-10 Finland

Dementia in Parkinson's disease without additional symptoms

812.3

82.5

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

82.5

1441

8469

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.9

82.4

1117

6076

R25.2

ICD-10 Finland

Cramp and spasm

2.6

82.1

472

1815

G24.4

ICD-10 Finland

Idiopathic orofacial dystonia

409.5

82.0

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.5

81.9

552

2291

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.6

81.7

484

1889

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.2

81.6

721

3360

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.8

81.0

419

1526

SFA10

NOMESCO Finland

One-surface restoration

1.3

80.8

8572

72355

N06AA12

ATC

doxepin; systemic

2.0

80.0

943

4894

G04BD08

ATC

solifenacin; oral

1.8

79.7

1254

7145

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

78.9

10355

90057

S01.0

ICD-10 Finland

Open wound of scalp

1.8

78.7

1376

8085

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.9

78.5

382

1347

R25.0

ICD-10 Finland

Abnormal head movements

22.9

78.5

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

78.2

3514

25720

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

77.9

2365

15973

F61.0

ICD-10 Finland

Mixed personality disorders

3.4

77.9

285

850

F32

ICD-10 Finland

Depressive episode

2.1

77.7

778

3806

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.3

77.2

292

889

F20.5

ICD-10 Finland

Residual schizophrenia

5.6

77.1

145

259

UKC02

NOMESCO Finland

Cystoscopy

1.5

76.7

2896

20482

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

76.6

3091

22151

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

76.5

6596

53828

Z3226

NOMESCO Finland

Physiotherapist

1.5

76.3

3024

21590

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

76.1

1008

5440

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

75.3

2792

19664

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

74.8

4207

32029

R52.2

ICD-10 Finland

Other chronic pain

2.2

74.5

636

2923

R20.2

ICD-10 Finland

Paraesthesia of skin

1.8

74.2

1096

6121

G24.1

ICD-10 Finland

Idiopathic familial dystonia

+∞

74.0

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

73.7

11530

102355

J01DB01

ATC

cefalexin; oral

1.4

73.7

14178

129915

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

5.6

73.7

139

249

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

73.4

796

4010

SPAT1243

SPAT

Psychiatric/psychological examination

2.8

73.1

368

1322

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

73.0

2391

16403

D12

ICPC

Constipation

2.1

72.9

681

3244

F20

ICD-10 Finland

Schizophrenia

5.5

72.6

140

256

N05AE04

ATC

ziprasidone; systemic

5.9

72.3

129

219

SPAT1263

SPAT

Sampling

1.3

72.2

6926

57276

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

72.1

7252

60383

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

71.9

7993

67496

P74

ICPC

Anxiety disorder/anxiety state

2.3

71.3

563

2504

R02

ICPC

Shortness of breath/dyspnoea

1.5

71.2

2216

15027

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.8

71.1

219

583

U07

ICPC

Urine symptom/complaint other

1.7

71.0

1306

7777

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.2

70.1

585

2663

SPAT1260

SPAT

Consultation of another employee

1.5

70.1

2960

21360

L02

ICPC

Back symptom/complaint

1.7

70.1

1509

9375

U02

ICPC

Urinary frequency/urgency

1.5

69.9

2325

15989

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.2

69.9

283

899

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

69.8

7233

60388

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

69.5

2377

16443

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

5.8

69.3

126

218

Z71.8

ICD-10 Finland

Other specified counselling

1.4

68.9

4717

37007

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

68.8

3319

24538

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

4.5

68.1

168

379

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

5.5

68.1

131

239

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

5.6

67.9

128

229

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.1

67.9

708

3514

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

67.7

2044

13758

29570

ICD-8 Finland

Schizophrenia, Schizo-affective type

7.6

67.7

125

R06.5

ICD-10 Finland

Mouth breathing

1.7

67.3

1349

8220

R11

ICD-10 Finland

Nausea and vomiting

1.7

67.3

1402

8631

A29

ICPC

General symptom/complaint other

1.5

67.1

2116

14378

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

67.1

1665

10711

G43.9

ICD-10 Finland

Migraine, unspecified

2.0

67.1

755

3852

SPAT1307

SPAT

Psychosocial counselling and guidance

2.0

66.8

741

3761

N04BC01

ATC

bromocriptine; oral

22.3

66.8

M54

ICD-10 Finland

Dorsalgia

1.6

66.5

1822

11995

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.4

66.3

445

1843

R41.0

ICD-10 Finland

Disorientation, unspecified

2.2

65.7

600

2832

C03CA01

ATC

furosemide; systemic

1.3

65.2

5567

45081

S18

ICPC

Laceration/cut

1.3

65.2

7664

64908

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

64.9

841

4501

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

3.4

64.9

239

716

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

4.6

64.9

155

341

N05AL01

ATC

sulpiride; systemic

3.0

64.9

291

981

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

2.7

64.6

342

1262

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

64.3

1196

7138

SFA20

NOMESCO Finland

Two-surface restoration

1.3

64.1

8895

76955

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

64.0

4958

39554

3338X

ICD-9 Finland

Other extrapyramidal disease and abnormal movement disorders, Fragments of torsion dystonia

+∞

63.6

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

63.5

1064

6166

W19

ICD-10 Finland

Unspecified fall

1.6

63.2

1621

10503

IHZ05, ,

SPAT

2.4

63.1

424

1757

J01CA08

ATC

pivmecillinam; oral

1.3

62.9

6283

51961

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

62.8

1149

6827

IGY02, ,

SPAT

3.8

62.6

191

505

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.5

62.6

215

616

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

62.6

1784

11845

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

8.0

62.5

105

N03AF02

ATC

oxcarbazepine; oral

2.2

62.5

540

2493

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.5

62.5

396

1597

R33

ICD-10 Finland

Retention of urine

1.6

62.1

1424

8977

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.2

61.5

563

2659

G24.2

ICD-10 Finland

Idiopathic nonfamilial dystonia

+∞

61.5

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.0

61.3

672

3395

F05.9

ICD-10 Finland

Delirium, unspecified

2.4

61.2

415

1727

XA402

NOMESCO Finland

ENMG

2.4

61.1

425

1789

L12

ICPC

Hand/finger symptom/complaint

1.5

61.0

2457

17527

R32

ICD-10 Finland

Unspecified urinary incontinence

2.2

60.9

524

2415

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

4.3

60.8

155

359

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.7

60.7

324

1200

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

5.0

60.7

131

265

F02.32

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly hallucinations

+∞

60.4

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.1

60.3

611

3000

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.7

60.3

1229

7516

R07.3

ICD-10 Finland

Other chest pain

1.6

60.2

1660

10933

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.5

59.6

203

579

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

59.4

8572

74246

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.2

59.2

528

2469

H03AA01

ATC

levothyroxine sodium; systemic

1.4

59.1

3732

28786

G04CA02

ATC

tamsulosin; oral

1.4

58.9

4061

31752

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

58.8

2091

14545

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

58.7

764

4093

N05AE05

ATC

lurasidone; oral

7.5

58.7

113

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

58.6

1653

10939

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

57.9

6278

52340

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

57.8

2898

21497

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

57.6

4301

34025

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

2.9

57.4

271

941

N05AF01

ATC

flupentixol; systemic

2.8

57.3

290

1045

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

57.3

4328

34291

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.5

57.1

361

1454

2957A

ICD-9 Finland

Schizophrenic psychoses, Schizo-affective type

6.6

57.1

141

Z01.2

ICD-10 Finland

Dental examination

1.3

57.0

6770

57092

J02AC01

ATC

fluconazole; systemic

1.3

56.9

5850

48395

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

56.6

1710

11486

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.2

56.6

491

2271

UJF32

NOMESCO Finland

Coloscopy

1.3

56.6

4406

35055

R27.0

ICD-10 Finland

Ataxia, unspecified

5.1

56.3

117

229

2959C

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]

6.7

56.2

134

R44.1

ICD-10 Finland

Visual hallucinations

4.6

56.1

132

287

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

56.0

2631

19283

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

56.0

2934

21921

F25.2

ICD-10 Finland

Schizoaffective disorder, mixed type

8.2

55.8

R4110

NOMESCO Finland

Physiotherapy

1.3

55.7

4442

35450

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

55.2

1966

13670

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.5

55.1

187

532

F45.8

ICD-10 Finland

Other somatoform disorders

1.8

54.9

864

4913

F22.0

ICD-10 Finland

Delusional disorder

2.8

54.8

270

959

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.8

54.8

873

4982

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

54.5

3470

26750

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

54.5

544

2657

G23.2

ICD-10 Finland

Multiple system atrophy, parkinsonian type [MSA-P]

+∞

54.2

WX290

NOMESCO Finland

Other blockage of nerve

1.3

54.2

6476

54551

EBA00

NOMESCO Finland

Extraction of tooth

1.3

54.1

5359

44043

F40.1

ICD-10 Finland

Social phobias

2.7

53.8

300

1137

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

53.7

6015

50231

F20.10

ICD-10 Finland

Raise schizophrenia continuously

5.8

53.7

167

G04BD04

ATC

oxybutynin; oral, transdermal

1.8

53.4

918

5354

L29

ICPC

Musculoskeletal sympt/complt other

1.6

53.4

1358

8769

R03DC03

ATC

montelukast; oral

1.4

53.3

2394

17392

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

1.9

53.2

689

3686

P98

ICPC

Psychosis NOS/other

4.7

53.2

123

264

A02BA02

ATC

ranitidine; systemic

1.4

52.9

3190

24368

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

6.0

52.9

156

SFA30

NOMESCO Finland

Three-surface restoration

1.3

52.6

6378

53769

ZY000

NOMESCO Finland

Hospital inpatient

3.3

52.5

202

623

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

52.3

1548

10345

K30

ICD-10 Finland

Functional dyspepsia

1.5

52.2

1689

11506

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.5

52.1

344

1414

2959E

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]

6.5

52.1

129

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

52.0

849

4878

F20.0

ICD-10 Finland

Paranoid schizophrenia

4.4

52.0

130

297

29530

ICD-8 Finland

Schizophrenia, Paranoid type

5.7

51.9

169

R01AD09

ATC

mometasone; nasal

1.3

51.6

6756

57462

C07AB07

ATC

bisoprolol; oral

1.3

51.5

8505

74380

M54.2

ICD-10 Finland

Cervicalgia

1.6

51.5

1152

7209

N06BA04

ATC

methylphenidate; oral

2.5

51.2

325

1312

IAB01, ,

SPAT

6.2

51.2

141

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

50.9

2144

15382

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

5.3

50.7

102

194

G04BD07

ATC

tolterodine; oral

1.8

50.7

857

4973

29510

ICD-8 Finland

Schizophrenia, Hebephrenic type

6.7

50.7

120

E0000UV, ,

ATC

1.3

50.2

6542

55546

J01MA02

ATC

ciprofloxacin; systemic

1.3

50.1

6465

54823

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

2.4

50.1

345

1446

H50.52

ICD-10 Finland

Exophoria

3.4

50.1

185

556

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

49.9

3912

31063

N01

ICPC

Headache

1.6

49.8

1396

9212

AA5QN, ,

NOMESCO Finland

92.0

49.8

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

3.2

49.8

196

613

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

9.9

49.7

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.3

49.7

378

1656

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

3.2

49.5

197

620

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

49.5

1622

11074

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.3

49.3

364

1574

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

49.3

3110

23899

R05

ICD-10 Finland

Cough

1.4

49.2

3297

25566

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.5

49.1

318

1296

M01AC06

ATC

meloxicam; systemic, rectal

1.3

49.1

5731

47968

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

6.6

49.1

118

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

49.0

3950

31472

Z2446

NOMESCO Finland

Social worker

1.7

49.0

947

5705

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

48.9

1672

11513

J45

ICD-10 Finland

Asthma

1.5

48.9

1538

10408

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

48.9

5666

47381

M54.1

ICD-10 Finland

Radiculopathy

1.9

48.8

622

3310

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

3.7

48.5

152

410

N06AA04

ATC

clomipramine; systemic

2.6

48.5

284

1103

G02CB01

ATC

bromocriptine; systemic

2.8

48.5

241

861

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.2

48.4

393

1769

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.5

48.4

313

1275

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.6

48.4

288

1128

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

48.3

870

5139

Z3231

NOMESCO Finland

Registered nurse

1.3

48.3

4375

35415

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.9

48.1

610

3240

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.8

48.1

795

4585

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.7

47.7

892

5323

SPAT1310

SPAT

Counselling related to known health issue

1.3

47.7

4992

41173

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.5

47.6

291

1155

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

47.5

6593

56304

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

2.3

47.0

356

1556

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

46.9

1992

14303

M01AB05

ATC

diclofenac; systemic, rectal

1.3

46.9

10652

96182

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

46.7

2813

21435

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

46.7

500

2506

R4120

NOMESCO Finland

Occupational therapy

1.7

46.3

994

6152

P28

ICPC

Limited function/disability (P)

3.6

46.2

155

438

L15

ICPC

Knee symptom/complaint

1.3

46.0

3651

28985

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

45.9

625

3398

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

45.8

1328

8824

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.6

45.8

148

408

M01AE02

ATC

naproxen; oral, rectal

1.2

45.7

8766

77564

A08

ICPC

Swelling

1.7

45.5

853

5093

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

3.9

45.5

136

355

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

45.4

705

3990

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

7.0

45.2

M01AH05

ATC

etoricoxib; oral

1.2

45.0

9591

85795

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

4.8

44.9

101

212

3331A

ICD-9 Finland

Other extrapyramidal disease and abnormal movement disorders, Essential and other specified forms of tremor

+∞

44.8

D01

ICPC

Abdominal pain/cramps general

1.5

44.6

1646

11499

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

44.5

3161

24681

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

44.4

6478

55520

U05

ICPC

Urination problems other

1.7

44.3

843

5055

N02AA05

ATC

oxycodone; systemic

1.3

44.3

2930

22638

P73

ICPC

Affective psychosis

5.0

44.0

185

IBA03

NOMESCO Finland

Psychotherapy evaluation

4.0

44.0

125

315

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.5

44.0

279

1127

A99

ICPC

Disease/condition unspecnature/site

1.5

43.8

1446

9877

Z00.0

ICD-10 Finland

General medical examination

1.3

43.8

2969

23021

G25.5

ICD-10 Finland

Other chorea

+∞

43.8

L86

ICPC

Back syndrome with radiating pain

1.7

43.7

926

5710

SPAT1167

SPAT

Insertion of urinary catheter

1.9

43.5

569

3054

IGV01

NOMESCO Finland

Psychiatric network contact

3.8

43.4

132

349

N06AA10

ATC

nortriptyline; systemic

2.3

43.4

322

1396

G04BD11

ATC

fesoterodine; oral

2.0

43.2

502

2589

F0230, G20,

ICD-10 Finland

428.8

43.2

I95.9

ICD-10 Finland

Hypotension, unspecified

2.5

42.9

280

1146

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

42.9

3601

28779

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

42.8

1110

7192

F0232, G20,

ICD-10 Finland

+∞

42.7

N05AD03

ATC

melperone; systemic

2.7

42.7

234

880

N07BB01

ATC

disulfiram; oral

1.9

42.7

552

2951

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

42.6

1710

12135

L84

ICD-10 Finland

Corns and callosities

1.9

42.5

555

2977

G43.3

ICD-10 Finland

Complicated migraine

2.8

42.4

218

793

D11

ICPC

Diarrhoea

1.5

42.4

1572

10988

N06AB08

ATC

fluvoxamine; oral

2.1

42.4

409

1973

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

3.8

42.3

129

342

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

42.2

1020

6498

R51

ICD-10 Finland

Headache

1.7

42.2

738

4323

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.5

42.0

1254

8384

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.7

42.0

819

4944

KMAK, ,

NOMESCO Finland

1.2

41.9

7515

65768

S29

ICPC

Skin symptom/complaint other

1.3

41.8

2969

23158

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

41.8

1195

7914

F20.1

ICD-10 Finland

Hebephrenic schizophrenia

9.0

41.5

R03BA02

ATC

budesonide; inhalant

1.4

41.4

2628

20153

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.7

41.4

735

4323

2959A

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]

6.0

41.4

123

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

5.5

41.2

144

C01CA01

ATC

etilefrine; systemic

3.4

41.1

151

453

130

Kela drug reimbursment

Malignant tumour

0.6

40.8

581

10115

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.1

40.8

416

2048

R50.9

ICD-10 Finland

Fever, unspecified

1.4

40.7

2235

16750

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

4.9

40.6

179

G04BD09

ATC

trospium; oral

2.0

40.6

436

2188

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

40.6

2182

16297

R03BA08

ATC

ciclesonide; inhalant

1.5

40.3

1247

8398

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

40.2

1464

10191

L14

ICPC

Leg/thigh symptom/complaint

1.5

40.2

1232

8280

R63.4

ICD-10 Finland

Abnormal weight loss

1.8

40.0

614

3463

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

4.2

40.0

107

258

A97

ICPC

No disease

1.3

39.9

2699

20887

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

39.7

2486

19013

A05

ICPC

Feeling ill

1.7

39.7

756

4532

L13

ICPC

Hip symptom/complaint

1.3

39.5

2873

22470

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.7

39.4

219

830

J01CA04

ATC

amoxicillin; systemic

1.3

39.4

13365

124800

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

39.2

1424

9906

H81

ICPC

Excessive ear wax

1.3

39.2

2780

21658

SPAT1244

SPAT

Occupational therapy

2.8

39.2

194

692

A11

ICPC

Chest pain NOS

1.5

39.2

1281

8725

E86

ICD-10 Finland

Volume depletion

2.0

39.1

418

2094

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

39.1

5571

47436

N05AX15

ATC

cariprazine; oral

6.2

38.9

107

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.9

38.7

471

2468

R30.1

ICD-10 Finland

Vesical tenesmus

2.1

38.6

350

1649

F20.8

ICD-10 Finland

Other schizophrenia

5.1

38.3

154

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

4.5

38.3

208

S70.0

ICD-10 Finland

Contusion of hip

1.8

38.3

620

3553

S72.0

ICD-10 Finland

Fracture of neck of femur

1.7

38.3

671

3933

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

38.3

990

6407

IFA99, ,

SPAT

6.4

38.3

SPAT1312

SPAT

General health counselling

1.3

38.2

4768

39959

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

38.2

1802

13154

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.6

38.1

844

5261

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

38.1

473

2496

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

6.2

38.1

106

D82

ICPC

Teeth/gum disease

1.3

38.1

5106

43149

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

38.0

3887

31802

A03FA02

ATC

cisapride; oral, rectal

1.5

38.0

1199

8106

AAW01

NOMESCO Finland

Implantation of intracranial stimulation device

133.6

37.7

R05

ICPC

Cough

1.3

37.7

3563

28859

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.9

37.6

520

2840

F25

ICD-10 Finland

Schizoaffective disorders

6.8

37.6

3339X

ICD-9 Finland

Other extrapyramidal disease and abnormal movement disorders, Other and unspecified extrapyramidal diseases and abnormal movement disorders

+∞

37.5

K03.66

ICD-10 Finland

Tooth plaque

1.6

37.5

1044

6871

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

4.0

37.4

107

271

K07.60

ICD-10 Finland

Snapping jaw

1.7

37.4

636

3695

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.3

37.4

282

1232

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

37.4

1987

14798

XKC03

NOMESCO Finland

Water cystometry

1.9

37.4

492

2646

L19

ICPC

Muscle symptom/complaint NOS

2.0

37.2

417

2125

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

37.2

3821

31267

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

37.2

1329

9216

K08.3

ICD-10 Finland

Retained dental root

1.5

37.1

1150

7744

G47.8

ICD-10 Finland

Other sleep disorders

2.8

37.1

185

663

L08

ICPC

Shoulder symptom/complaint

1.3

37.0

3272

26265

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.8

36.9

618

3575

H53.2

ICD-10 Finland

Diplopia

1.9

36.8

493

2667

G72.8

ICD-10 Finland

Other specified myopathies

2.3

36.7

274

1192

G04CA01

ATC

alfuzosin; oral

1.4

36.6

1937

14411

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.7

36.6

628

3658

N04BC07

ATC

apomorphine; parenteral

+∞

36.5

L16

ICPC

Ankle symptom/complaint

1.4

36.4

1602

11549

IHZ04, ,

SPAT

3.1

36.4

148

473

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

36.3

4425

36947

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

1.8

36.2

545

3056

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

36.1

3520

28600

N30

ICD-10 Finland

Cystitis

1.5

36.1

1127

7602

IGY99, ,

SPAT

3.0

36.0

160

538

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.0

36.0

421

2178

J45.1

ICD-10 Finland

Nonallergic asthma

1.5

35.9

1069

7136

R03AK08

ATC

formoterol and beclometasone; inhalant

1.7

35.9

629

3686

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

35.9

1162

7897

J01AA02

ATC

doxycycline; systemic

1.2

35.8

12974

121180

G54.0

ICD-10 Finland

Brachial plexus disorders

2.2

35.8

321

1506

SPAT1235

SPAT

Mental health, emotional support

3.5

35.7

120

340

SPAT1153

SPAT

Removal of sutures

1.2

35.7

5054

42899

R00.2

ICD-10 Finland

Palpitations

1.5

35.7

1071

7161

N06AX17

ATC

milnacipran; oral

2.8

35.7

177

633

ZXE10

NOMESCO Finland

More than one and less than three hours

1.2

35.5

5643

48499

K07

ICPC

Swollen ankles/oedema

1.6

35.5

761

4706

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

35.4

6627

57927

M02AA07

ATC

piroxicam; topical

1.2

35.0

5767

49737

R06AE07

ATC

cetirizine; oral

1.2

34.9

6526

57017

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.9

34.9

167

586

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.6

34.9

872

5598

29999

ICD-8 Finland

Unspecified psychosis

4.3

34.7

208

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.3

34.6

270

1197

L60.0

ICD-10 Finland

Ingrowing nail

1.7

34.6

671

4042

R26

ICD-10 Finland

Abnormalities of gait and mobility

5.2

34.6

138

SPAT1211

SPAT

Application of soft bandage

1.5

34.5

1329

9345

R01AD08

ATC

fluticasone; nasal

1.3

34.4

4037

33515

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

3.9

34.3

102

266

A02BC04

ATC

rabeprazole; oral

1.5

34.3

1218

8431

WZC00, ,

SPAT

1.4

34.3

1393

9895

SPAT1360

SPAT

Extensive global examination

1.5

34.2

1111

7552

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

4.7

33.9

167

R1250, ,

SPAT

2.2

33.9

273

1227

U01

ICPC

Dysuria/painful urination

1.5

33.8

1106

7528

S00.0

ICD-10 Finland

Superficial injury of scalp

2.0

33.8

365

1837

R44.3

ICD-10 Finland

Hallucinations, unspecified

3.7

33.7

107

292

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

3.5

33.7

114

325

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.3

33.7

126

383

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

2.8

33.5

170

615

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

33.5

5001

42629

SPAT1241

SPAT

Extensive assessment of psychosocial situation

2.9

33.4

154

529

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.9

33.3

154

530

P01AB01

ATC

metronidazole; oral, rectal

1.2

33.3

5984

52001

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

33.2

518

2937

R03BA05

ATC

fluticasone; inhalant

1.3

33.2

2601

20510

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

33.2

2470

19339

R96

ICPC

Asthma

1.4

33.1

1401

10021

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

2.9

33.1

157

548

F20.34

ICD-10 Finland

Undifferentiated schizophrenia with partial recurrence

4.8

33.1

151

N05AH05

ATC

asenapine; oral

8.6

33.1

F06.0

ICD-10 Finland

Organic hallucinosis

5.4

33.0

118

SPAT1252

SPAT

Overall medication plan or its review

1.5

33.0

1093

7459

S22

ICPC

Nail symptom/complaint

1.5

33.0

951

6303

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.7

32.9

179

672

M01AH01

ATC

celecoxib; oral

1.3

32.8

2741

21796

K11.72

ICD-10 Finland

Xerostomia

8.0

32.8

WX002

NOMESCO Finland

Sedation and analgesia

1.3

32.7

3021

24341

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.4

32.7

1349

9608

SPAT1050

SPAT

Extensive neurological examination

2.0

32.7

342

1702

Z29

ICPC

Social problem NOS

2.1

32.6

300

1422

IHZ07, ,

SPAT

3.6

32.6

107

299

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

32.5

4123

34503

M54.3

ICD-10 Finland

Sciatica

1.6

32.5

859

5584

AA1AA

NOMESCO Finland

Head X-ray examination

2.9

32.5

152

527

N06BA07

ATC

modafinil; oral

5.1

32.3

135

D06

ICPC

Abdominal pain localized other

1.5

32.3

1203

8401

M43.1

ICD-10 Finland

Spondylolisthesis

1.7

32.3

584

3454

S22.3

ICD-10 Finland

Fracture of rib

1.5

32.2

1035

7019

R39.1

ICD-10 Finland

Other difficulties with micturition

1.8

32.2

478

2671

R4120, ,

SPAT

2.9

32.1

152

530

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

32.0

4339

36569

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

4.2

32.0

196

Z2221

NOMESCO Finland

Medical doctor

1.2

31.9

4102

34366

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

3.9

31.9

235

G21.2

ICD-10 Finland

Secondary parkinsonism due to other external agents

317.7

31.9

F02.34

ICD-10 Finland

Dementia in Parkinson's disease, other additional symptoms of mixed type

317.7

31.9

29560

ICD-8 Finland

Residual schizophrenia

7.7

31.8

U71

ICPC

Cystitis/urinary infection other

1.5

31.8

946

6314

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

31.7

1396

10056

G04CB01

ATC

finasteride; oral

1.4

31.7

1825

13748

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

2.8

31.7

158

567

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

31.6

982

6613

N05AE03

ATC

sertindole; oral

5.9

31.6

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.5

31.5

1146

7966

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

31.5

3243

26471

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

31.5

1106

7637

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

31.4

1773

13314

IEV99, ,

SPAT

7.2

31.3

ICB03, ,

SPAT

5.5

31.2

110

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

31.1

2930

23647

L99

ICPC

Musculoskeletal disease other

2.0

31.1

329

1644

Z01.7

ICD-10 Finland

Laboratory examination

1.3

31.0

2059

15849

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

30.9

1752

13163

SDA03

NOMESCO Finland

Periodontal treatment

1.2

30.9

5608

48690

2953E

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]

5.4

30.9

111

G62.8

ICD-10 Finland

Other specified polyneuropathies

2.8

30.9

150

531

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.4

30.9

1221

8625

N05CD02

ATC

nitrazepam; oral

2.1

30.9

282

1334

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

3.4

30.8

108

315

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.0

30.8

349

1786

R49.08

ICD-10 Finland

Other specified dysphonia

2.0

30.8

325

1622

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.8

30.8

490

2795

L84

ICPC

Back syndrome without radiat pain

1.6

30.6

660

4087

H02AB02

ATC

dexamethasone; systemic

0.7

30.6

862

12776

F41.00

ICD-10 Finland

Moderate panic disorder

2.5

30.6

190

762

A06AX04

ATC

linaclotide; oral

4.4

30.5

174

SPAT1101

SPAT

Orthostatic test

1.6

30.5

716

4529

Z50.5

ICD-10 Finland

Speech therapy

2.5

30.4

195

793

R23

ICPC

Voice symptom/complaint

2.1

30.4

305

1495

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.4

30.4

1193

8416

SPAT1281

SPAT

Other administrative function

1.5

30.3

1123

7834

F61

ICD-10 Finland

Mixed and other personality disorders

4.3

30.3

183

S20.2

ICD-10 Finland

Contusion of thorax

1.6

30.3

728

4630

A06AC51

ATC

ispaghula, combinations; oral

1.6

30.2

719

4562

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.4

30.1

202

839

F31.21

ICD-10 Finland

Bipolar disorder, manic episode with mood incongruent psychotic symptoms

6.7

30.1

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

30.1

7789

69886

A27

ICPC

Fear of other disease NOS

1.6

30.0

718

4560

P25

ICPC

Phase of life problem adult

1.8

29.9

478

2730

ZYC01, ,

SPAT

1.5

29.9

1154

8113

N05AX16

ATC

brexpiprazole; oral

5.7

29.8

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

29.7

1105

7713

-1, ,

NOMESCO Finland

1.2

29.7

4491

38239

R1260

NOMESCO Finland

Evaluation of communicative skills

2.2

29.7

262

1223

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

4.9

29.7

130

R12

ICD-10 Finland

Heartburn

1.5

29.7

1102

7691

K10.3

ICD-10 Finland

Alveolitis of jaws

1.7

29.6

558

3338

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

29.5

3769

31518

F44.4

ICD-10 Finland

Dissociative motor disorders

8.1

29.4

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

2.4

29.4

196

812

Z71.9

ICD-10 Finland

Counselling, unspecified

1.5

29.4

966

6580

F20.08

ICD-10 Finland

Paranoid schizophrenia other definite

5.7

29.3

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

29.3

2607

20879

34200

ICD-8 Finland

Paralysis agitans, Parkinsonismus

+∞

29.2

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.0

29.0

325

1657

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

5.6

29.0

N05AX13

ATC

paliperidone; systemic

4.1

29.0

198

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.0

28.9

315

1592

F33

ICD-10 Finland

Recurrent depressive disorder

2.2

28.8

244

1121

F32.8

ICD-10 Finland

Other depressive episodes

2.4

28.8

203

863

G25.6

ICD-10 Finland

Drug-induced tics and other tics of organic origin

292.5

28.8

SPAT1262

SPAT

Handing over of treatment supplies

1.3

28.8

2715

21899

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.2

28.7

243

1116

AA1BD

NOMESCO Finland

Extensive CT of head and brain

1.9

28.7

390

2121

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.4

28.7

200

846

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.0

28.6

317

1610

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.3

28.6

222

984

A01AB09

ATC

miconazole; local oral

1.4

28.5

1281

9255

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

28.5

3114

25563

183

Kela drug reimbursment

Lamotrigin and topiramate

2.9

28.4

131

451

D07AA02

ATC

hydrocortisone; topical

1.3

28.3

1852

14214

Z08

ICPC

Social welfare problem

2.4

28.2

185

761

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.6

28.2

609

3773

D07AC01

ATC

betamethasone; topical

1.2

28.2

5479

47785

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

2.4

28.2

194

816

EBA30

NOMESCO Finland

Extraction of root of tooth

1.5

28.2

818

5429

N05BA02

ATC

chlordiazepoxide; systemic

1.9

28.2

340

1779

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

3.3

28.2

105

319

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.6

28.2

661

4180

SPAT1104

SPAT

Monitoring of emergency patient

1.5

28.1

979

6745

M01AH02

ATC

rofecoxib; oral

1.3

28.1

1966

15231

N76.0

ICD-10 Finland

Acute vaginitis

1.6

28.1

621

3869

J01DA01

ATC

[U] cefalexin

1.2

28.1

9813

90173

F20.19

ICD-10 Finland

Hebefren schizophrenia UNS

7.7

28.0

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

28.0

1345

9832

ZXA10

NOMESCO Finland

Bilateral

1.3

27.9

2877

23450

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.4

27.6

1078

7592

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

1.9

27.6

339

1784

F25.0

ICD-10 Finland

Schizoaffective disorder, manic type

5.2

27.6

108

E61.1

ICD-10 Finland

Iron deficiency

2.2

27.4

242

1131

D09

ICPC

Nausea

1.7

27.3

547

3325

R30.0

ICD-10 Finland

Dysuria

1.7

27.3

564

3456

F41.3

ICD-10 Finland

Other mixed anxiety disorders

2.6

27.3

159

619

Z50.1

ICD-10 Finland

Other physical therapy

1.5

27.2

774

5116

N03AX14

ATC

levetiracetam; systemic

1.8

27.2

401

2238

TKC20

NOMESCO Finland

Catheterisation of bladder

1.4

27.0

1056

7439

ZXY49

NOMESCO Finland

Other health care provider

4.3

27.0

157

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.8

27.0

137

497

R26.2

ICD-10 Finland

Difficulty in walking, not elsewhere classified

2.3

27.0

203

888

G43

ICD-10 Finland

Migraine

1.7

27.0

486

2872

U13

ICPC

Bladder symptom/complaint other

1.8

26.8

437

2511

F20.02

ICD-10 Finland

Paranoid schizophrenia stable periodically

4.8

26.8

126

N05BA09

ATC

clobazam; oral

3.5

26.8

256

F95.9

ICD-10 Finland

Tic disorder, unspecified

9.7

26.7

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.6

26.7

593

3701

R49.03

ICD-10 Finland

Atrophic dysphonia

2.3

26.7

204

899

N02CC07

ATC

frovatriptan; oral

1.8

26.6

408

2302

IFA01, ,

SPAT

7.0

26.6

29500

ICD-8 Finland

Schizophrenia, Simple type

5.8

26.6

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.1

26.5

247

1179

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

26.4

1862

14434

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.5

26.4

805

5398

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

26.4

1941

15139

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.5

26.4

869

5922

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

26.4

3856

32652

D19

ICPC

Teeth/gum symptom/complaint

1.2

26.3

3754

31709

H02AB06

ATC

prednisolone; systemic

1.2

26.3

7578

68345

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.0

26.3

293

1493

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

1.9

26.2

354

1922

K08.80

ICD-10 Finland

Toothache NOS

1.4

26.2

1067

7576

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

3.4

26.0

280

G23.3

ICD-10 Finland

Multiple system atrophy, cerebellar type [MSA-C]

+∞

26.0

R52.1

ICD-10 Finland

Chronic intractable pain

2.6

26.0

145

552

N39.3

ICD-10 Finland

Stress incontinence

1.4

26.0

1018

7172

R01AD58

ATC

fluticasone, combinations; nasal

1.3

26.0

3034

25069

S04

ICPC

Lump/swelling localized

1.4

26.0

1413

10537

IEY01

NOMESCO Finland

Psychoeducation, individual

3.5

25.8

253

SBB10

NOMESCO Finland

Dental impressions

1.5

25.7

769

5135

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.3

25.7

190

825

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

25.7

1881

14656

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

25.7

2831

23231

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

4.3

25.6

151

3AX0X, ,

NOMESCO Finland

93.5

25.6

R03BA01

ATC

beclometasone; inhalant

1.3

25.6

2023

15930

SPAT1058

SPAT

PEF monitoring instruction

1.4

25.5

1177

8540

SPAT1284

SPAT

Extensive health certificate

1.8

25.5

365

2018

J46

ICD-10 Finland

Status asthmaticus

1.8

25.4

399

2268

C05AA08

ATC

fluocortolone; rectal, topical

1.3

25.4

1972

15490

N27

ICPC

Fear of neurological disease other

2.1

25.4

255

1252

N06AX18

ATC

reboxetine; oral

2.4

25.4

167

689

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.5

25.4

694

4547

ZXY82

NOMESCO Finland

Nurse in multidisciplinary team

4.7

25.4

124

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.3

25.4

1527

11567

SPAT1097

SPAT

Recording of ECG

1.3

25.3

2273

18193

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

25.3

3249

27116

R21

ICPC

Throat symptom/complaint

1.3

25.3

2494

20194

2951C

ICD-9 Finland

Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]

5.8

25.3

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

3.0

25.3

114

388

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.5

25.3

203

4232

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.5

25.2

810

5490

R03AC03

ATC

terbutaline; inhalant

1.3

25.2

1921

15048

SCA02

NOMESCO Finland

Preventive oral health care

1.4

25.2

1242

9114

SPAT1251

SPAT

Organisation of medication

1.6

25.2

520

3187

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.3

25.1

193

852

G72.9

ICD-10 Finland

Myopathy, unspecified

2.7

25.1

131

483

IER01

NOMESCO Finland

Psychoeducation, group

3.6

25.0

220

F45.0

ICD-10 Finland

Somatization disorder

3.6

25.0

234

SPAT1139

SPAT

Nutrition survey

1.7

25.0

486

2931

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.7

24.9

447

2640

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

2.5

24.9

149

588

XG466

NOMESCO Finland

Sleep oxymetry

1.7

24.9

437

2566

A07AA02

ATC

nystatin; oral

1.5

24.8

874

6035

S21

ICPC

Skin texture symptom/complaint

1.3

24.8

2068

16395

D64.9

ICD-10 Finland

Anaemia, unspecified

1.3

24.7

1684

12990

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

24.7

1368

10231

H02.3

ICD-10 Finland

Blepharochalasis

1.4

24.6

960

6761

Z75.5

ICD-10 Finland

Holiday relief care

2.6

24.6

141

545

WZC00

NOMESCO Finland

Treatment plan or consultation

1.2

24.5

5363

47149

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

24.4

2560

20874

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.5

24.4

157

641

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

24.4

4096

35126

R31

ICD-10 Finland

Unspecified haematuria

1.3

24.4

1565

11967

M54.8

ICD-10 Finland

Other dorsalgia

1.6

24.3

588

3746

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

24.3

1160

8465

SPAT1246

SPAT

Screening of depression or other psychiatric problem

1.7

24.3

436

2575

H13

ICPC

Plugged feeling ear

1.2

24.2

2949

24458

SPAT1237

SPAT

Psychotherapy

3.4

24.2

249

R01AD12

ATC

fluticasone furoate; nasal

1.2

24.1

4065

34868

F51

ICD-10 Finland

Nonorganic sleep disorders

1.7

24.1

455

2725

R26.0

ICD-10 Finland

Ataxic gait

4.1

24.0

159

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.6

23.9

619

4006

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.3

23.9

1835

14386

R41.3

ICD-10 Finland

Other amnesia

1.7

23.9

458

2754

ICB01, ,

SPAT

3.2

23.8

286

N89

ICPC

Migraine

1.9

23.8

314

1693

G93.3

ICD-10 Finland

Postviral fatigue syndrome

3.9

23.8

173

AAG10

NOMESCO Finland

Stereotactic intracranial destruction of nucleus or nerve tract

240.3

23.6

M01AX17

ATC

nimesulide; oral

1.2

23.6

3659

31114

R63.1

ICD-10 Finland

Polydipsia

4.3

23.5

136

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

5.8

23.5

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.6

23.4

533

3347

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

3.8

23.4

184

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.5

23.4

150

612

Z11

ICPC

Compliance/being ill problem

2.8

23.4

117

422

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.4

23.3

958

6809

L05

ICPC

Flank/axilla symptom/complaint

1.5

23.3

827

5719

N05BA05

ATC

potassium clorazepate; oral

2.5

23.3

150

613

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1.9

23.3

290

1535

H50.31

ICD-10 Finland

Intermittent exotropia

2.9

23.3

108

374

TKC22

NOMESCO Finland

Catheterisation instruction

1.8

23.3

339

1886

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.4

23.2

155

644

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.3

23.2

1677

13037

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.0

23.1

265

1365

R74

ICPC

Upper respiratory infection acute

1.2

22.9

3856

33043

F02.31

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly paranoidism

+∞

22.9

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

3.3

22.9

268

F51.5

ICD-10 Finland

Nightmares

7.6

22.9

F48.0

ICD-10 Finland

Neurasthenia

4.4

22.8

127

A03CA02

ATC

clidinium and psycholeptics; oral

1.4

22.8

863

6044

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

1.7

22.8

386

2245

R2110

NOMESCO Finland

Giving the first information

1.4

22.7

858

6004

R5599

NOMESCO Finland

Other rehabilitation service

1.8

22.7

372

2142

N05AC01

ATC

periciazine; systemic

3.4

22.7

235

S80.0

ICD-10 Finland

Contusion of knee

1.4

22.7

921

6533

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

22.7

1174

8682

F03

ICD-10 Finland

Unspecified dementia

1.5

22.7

659

4376

E000001, ,

ATC

1.2

22.6

2748

22768

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

3.6

22.6

207

N07XX06

ATC

tetrabenazine; oral

230.3

22.6

F28

ICD-10 Finland

Other nonorganic psychotic disorders

4.5

22.6

120

J01MA06

ATC

norfloxacin; oral

1.3

22.5

1887

14962

M02AA10

ATC

ketoprofen; topical

1.3

22.5

2334

18997

A01AB04

ATC

amphotericin B; local oral

1.5

22.5

685

4594

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.8

22.4

340

1916

R06.4

ICD-10 Finland

Hyperventilation

2.1

22.3

207

987

SPAT1325

SPAT

Vaccination

1.2

22.3

5337

47197

ZXA00

NOMESCO Finland

Right side

1.2

22.3

4098

35402

F20.01

ICD-10 Finland

Paranoid schizophrenia periodically with gradual deterioration

4.9

22.2

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

22.0

1791

14140

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.4

22.0

963

6921

2962E

ICD-9 Finland

Affective psychoses, Major depressive disorder, single episode[PSYCH.BIPOLARIS MANICA,VAIKEA-ASTE,PSYKOOT PIIRTEIT]

6.8

22.0

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

1.9

22.0

298

1621

M41.9

ICD-10 Finland

Scoliosis, unspecified

2.2

22.0

185

849

A03

ICPC

Fever

1.3

22.0

2045

16427

S20

ICPC

Corn/callosity

1.8

21.9

308

1695

C07AB02

ATC

metoprolol; systemic

1.2

21.9

3243

27427

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.6

21.9

468

2896

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.8

21.8

337

1908

N86

ICPC

Multiple sclerosis

3.0

21.8

323

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

21.8

5845

52156

OAB93, ,

SPAT

1.6

21.8

532

3399

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

4.4

21.7

124

K04.08

ICD-10 Finland

Other specified pulpit

1.5

21.6

808

5643

F31.2

ICD-10 Finland

Bipolar affective disorder, current episode manic with psychotic symptoms

4.5

21.6

116

N04BX01

ATC

tolcapone; oral

220.2

21.6

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

2.6

21.6

121

463

IAA01, ,

SPAT

3.2

21.6

268

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.2

21.5

3590

30712

J01FA06

ATC

roxithromycin; oral

1.2

21.5

5937

53086

AA40B, ,

NOMESCO Finland

3.1

21.5

284

R49.01

ICD-10 Finland

Functional dysphonia

1.7

21.4

399

2381

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.3

21.4

1373

10491

AXX01

NOMESCO Finland

Memory assessment

4.5

21.4

113

K04.0

ICD-10 Finland

Pulpitis

1.4

21.4

1026

7492

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

1.9

21.4

281

1515

K02

ICD-10 Finland

Dental caries

1.4

21.3

871

6185

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.3

21.3

1862

14836

R4130, ,

SPAT

4.3

21.2

126

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

21.2

6217

55847

A07EA06

ATC

budesonide; oral, local oral

1.6

21.2

459

2850

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.2

21.1

3626

31096

R40.0

ICD-10 Finland

Somnolence

3.8

21.1

170

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

2.9

21.1

345

E66.01

ICD-10 Finland

Obesity due to excess calories

1.4

21.1

1013

7398

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.2

21.1

183

851

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.3

21.1

155

673

TCE00

NOMESCO Finland

Therapeutic injection into extraocular muscle

33.8

21.1

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.2

21.0

169

763

R06AX27

ATC

desloratadine; oral

1.2

20.9

3619

31057

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

20.9

3195

27094

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.3

20.9

1229

9271

Z01.9

ICD-10 Finland

Special examination, unspecified

1.4

20.9

805

5657

IAA02, ,

SPAT

5.9

20.8

L29.9

ICD-10 Finland

Pruritus, unspecified

1.7

20.8

363

2129

IGP01

NOMESCO Finland

Psychiatric family contact

3.2

20.8

264

M35.7

ICD-10 Finland

Hypermobility syndrome

2.3

20.8

153

665

G04CB02

ATC

dutasteride; oral

1.4

20.7

1146

8563

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.4

20.7

1008

7379

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

20.7

4211

36674

G21

ICD-10 Finland

Secondary parkinsonism

76.9

20.7

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

20.6

14760

141885

A98

ICPC

Health maint/preventive medicine

1.3

20.6

16682

162395

UJD02

NOMESCO Finland

Gastroscopy

1.5

20.6

674

4590

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.6

20.5

517

3326

L09

ICPC

Arm symptom/complaint

1.5

20.4

614

4109

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

2.5

20.4

128

518

N02CC03

ATC

zolmitriptan; nasal, oral

1.5

20.3

572

3774

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

2.0

20.3

203

997

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.3

20.3

1602

12597

IBB03

NOMESCO Finland

Assessment of vocational rehabilitation needs in a mental health context

4.5

20.2

110

N02AJ13

ATC

tramadol and paracetamol; systemic

1.8

20.2

300

1680

SGA01

NOMESCO Finland

Emergency treatment

1.3

20.1

1903

15310

SFA00

NOMESCO Finland

Small restoration

1.3

20.0

1799

14383

N05AB01

ATC

dixyrazine; systemic

2.2

19.9

168

773

F20.20

ICD-10 Finland

Catatonic schizophrenia continuously

7.3

19.9

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.6

19.8

431

2678

S01.8

ICD-10 Finland

Open wound of other parts of head

2.0

19.8

208

1040

3321A

ICD-9 Finland

Parkinson's disease, Secondary Parkinsonism

+∞

19.8

R03BB04

ATC

tiotropium bromide; inhalant

1.3

19.8

1519

11898

R01AD01

ATC

beclometasone; nasal

1.3

19.8

2014

16341

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

2.8

19.8

358

H02.4

ICD-10 Finland

Ptosis of eyelid

1.6

19.8

411

2526

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.3

19.7

1995

16174

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.4

19.7

740

5174

IEV99

NOMESCO Finland

Other psychiatric network intervention

3.6

19.7

174

30188

ICD-8 Finland

Personality disorders, Alia definita

3.2

19.7

242

J01MA12

ATC

levofloxacin; systemic

1.2

19.7

2769

23272

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

1.8

19.7

276

1520

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

1.8

19.7

276

1520

L01BC06

ATC

capecitabine; oral

0.5

19.6

187

3675

R83

ICPC

Respiratory infection other

1.2

19.6

2910

24589

F02.3

ICD-10 Finland

Dementia in Parkinson disease

105.2

19.5

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

2.0

19.5

205

1025

L04

ICPC

Chest symptom/complaint

1.4

19.5

820

5853

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.0

19.5

211

1067

X58

ICD-10 Finland

Exposure to other specified factors

1.3

19.5

1783

14283

H01

ICPC

Ear pain/earache

1.3

19.4

1397

10845

P27

ICPC

Fear of mental disorder

2.3

19.4

138

591

N18

ICPC

Paralysis/weakness

1.8

19.4

288

1613

M77.4

ICD-10 Finland

Metatarsalgia

1.4

19.4

728

5090

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

1.9

19.4

235

1235

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

2.6

19.4

111

430

IEY02

NOMESCO Finland

Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)

4.3

19.4

114

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

3.4

19.4

195

Z60.8

ICD-10 Finland

Other problems related to social environment

3.7

19.3

167

IEY06

NOMESCO Finland

Psychiatric treatment and rehabilitation coaching

4.6

19.3

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.9

19.2

235

1238

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.5

19.2

692

4800

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

2.9

19.2

309

F60.7

ICD-10 Finland

Dependent personality disorder

3.4

19.2

206

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.6

19.1

503

3269

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

3.5

19.1

187

R03AK11

ATC

formoterol and fluticasone; inhalant

1.7

19.1

319

1849

R1420, ,

SPAT

4.1

19.1

128

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.3

19.1

1606

12729

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.3

19.0

1404

10938

XF402

NOMESCO Finland

ECG with work load test

1.3

19.0

1555

12280

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.4

19.0

975

7200

WX723

NOMESCO Finland

CPAP therapy

1.6

18.9

483

3119

KCV04

NOMESCO Finland

Distension of bladder with fluid

2.3

18.9

144

636

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

18.9

2776

23427

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.4

18.8

725

5094

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

18.8

2738

23082

F0234, G20,

ICD-10 Finland

+∞

18.7

F44.88

ICD-10 Finland

Other definite dissociation disorder

8.1

18.7

S97

ICPC

Chronic ulcer skin

1.4

18.7

878

6387

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.5

18.7

507

3318

Z73.6

ICD-10 Finland

Limitation of activities due to disability

2.3

18.7

132

564

N88

ICPC

Epilepsy

2.8

18.6

320

R10.2

ICD-10 Finland

Pelvic and perineal pain

1.8

18.5

283

1600

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

3.0

18.5

267

A46

ICD-10 Finland

Erysipelas

1.2

18.5

2160

17792

G35

ICD-10 Finland

Multiple sclerosis

2.1

18.5

180

876

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.3

18.5

1590

12636

R25.3

ICD-10 Finland

Fasciculation

3.3

18.5

206

R15

ICD-10 Finland

Faecal incontinence

1.6

18.5

399

2477

29630

ICD-8 Finland

Affective psychoses, Manic-depressive psychosis, circular type

6.2

18.4

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.4

18.4

812

5846

SPAT1172

SPAT

Guidance concerning hydration

1.7

18.4

357

2157

F21

ICD-10 Finland

Schizotypal disorder

3.1

18.4

242

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.5

18.4

551

3686

ZXE00

NOMESCO Finland

One hour or less

1.2

18.3

5783

52086

ZXH06, ,

SPAT

1.5

18.3

569

3835

B03BA03

ATC

hydroxocobalamin; parenteral

1.4

18.3

839

6082

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

3.7

18.2

155

G50.1

ICD-10 Finland

Atypical facial pain

1.9

18.2

230

1225

SPAT1276

SPAT

Outlining of treatment with patient or their family members

1.7

18.2

324

1912

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

18.2

5679

51096

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.2

18.2

3172

27197

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

3.7

18.1

151

N06BA12

ATC

lisdexamfetamine; oral

2.9

18.1

286

N02CC05

ATC

almotriptan; oral

1.6

18.1

387

2395

L76

ICPC

Fracture: other

1.6

18.1

418

2636

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.5

18.1

601

4103

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.5

18.1

528

3512

S94

ICPC

Ingrowing nail

1.9

18.1

226

1201

R06AE09

ATC

levocetirizine; oral

1.3

18.0

1753

14138

29610

ICD-8 Finland

Affective psychoses, Manic-depression psychosis, manic type

5.4

18.0

IEY21

NOMESCO Finland

Other intensified psychiatric treatment

4.6

17.9

J20

ICD-10 Finland

Acute bronchitis

1.3

17.9

1346

10511

H92.0

ICD-10 Finland

Otalgia

1.4

17.8

693

4880

N05AB02

ATC

fluphenazine; systemic

2.6

17.8

373

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

4.0

17.7

122

R44.0

ICD-10 Finland

Auditory hallucinations

3.1

17.7

232

R5130, ,

SPAT

3.4

17.7

187

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.0

17.7

180

891

H02AB04

ATC

methylprednisolone; systemic

1.2

17.7

2018

16577

N02CD03

ATC

fremanezumab; systemic

2.7

17.6

330

IBB01

NOMESCO Finland

Psychiatric functioning capacity evaluation

4.3

17.5

106

N02CC04

ATC

rizatriptan; oral

1.5

17.5

575

3918

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.5

17.5

205

3776

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.5

17.5

628

4355

J01FA10

ATC

azithromycin; systemic

1.1

17.5

8214

76017

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

17.5

1588

12703

C07AA07

ATC

sotalol; systemic

1.5

17.5

553

3741

G44.0

ICD-10 Finland

Cluster headache syndrome

2.3

17.5

131

575

XQ800

NOMESCO Finland

Prick test

1.4

17.5

822

5984

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

3.0

17.4

255

29830

ICD-8 Finland

Other psychoses, Acute paranoid reaction

4.1

17.4

115

TPH04

NOMESCO Finland

Cathetrisation of vein

1.2

17.4

3209

27640

ZXY60

NOMESCO Finland

2-person team, nurses

3.4

17.4

184

WYA20

NOMESCO Finland

Home visit

1.8

17.4

247

1366

G03DC03

ATC

lynestrenol; oral

1.9

17.4

228

1230

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

1.7

17.4

284

1638

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

2.6

17.4

366

S03.0

ICD-10 Finland

Dislocation of jaw

2.8

17.3

316

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.2

17.3

135

603

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.6

17.3

400

2526

X15

ICPC

Vaginal symptom/complaint other

1.6

17.3

363

2239

A04AA02

ATC

granisetron; systemic, transdermal

0.6

17.3

421

6441

R06.2

ICD-10 Finland

Wheezing

1.5

17.3

547

3702

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

17.2

1241

9633

W06

ICD-10 Finland

Fall involving bed

2.3

17.2

128

560

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

1.8

17.2

241

1328

N02CD01

ATC

erenumab; parenteral

2.7

17.2

328

R45.1

ICD-10 Finland

Restlessness and agitation

4.1

17.2

112

F60.5

ICD-10 Finland

Anankastic personality disorder

2.4

17.2

120

511

Z43.5

ICD-10 Finland

Attention to cystostomy

2.5

17.2

102

403

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.5

17.2

606

4190

K05.18

ICD-10 Finland

Chronic gingivitis

1.4

17.1

787

5705

E03

ICD-10 Finland

Other hypothyroidism

1.4

17.1

778

5630

G04BD10

ATC

darifenacin; oral

2.4

17.1

113

469

AA1BG, ,

SPAT

1.9

17.0

210

1111

ZXE22

NOMESCO Finland

Procedure duration at least 4 but less than 5 hours

4.3

17.0

100

P80

ICPC

Personality disorder

3.4

17.0

177

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

3.6

17.0

158

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.7

17.0

339

2064

E66.8

ICD-10 Finland

Other obesity

1.5

17.0

603

4174

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.5

16.9

577

3962

P15

ICPC

Chronic alcohol abuse

1.7

16.9

311

1854

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

2.8

16.9

298

WX780

NOMESCO Finland

Remote monitoring CPAP

1.5

16.9

502

3354

U29

ICPC

Urinary symptom/complaint other

1.6

16.9

409

2612

F30.20

ICD-10 Finland

Mania with mood-congruent psychotic symptoms

4.9

16.8

S01

ICPC

Pain/tenderness of skin

1.5

16.8

602

4174

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

2.1

16.8

164

800

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

3.1

16.8

224

P18

ICPC

Medication abuse

2.9

16.8

277

K90

ICPC

Stroke/cerebrovascular accident

1.6

16.7

409

2617

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

2.5

16.7

391

ZXH01

NOMESCO Finland

Procedure performed within operation theatre

5.0

16.6

Z00.8

ICD-10 Finland

Other general examinations

1.3

16.6

995

7524

C10AC01

ATC

colestyramine; oral

1.6

16.6

360

2238

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.3

16.6

1444

11487

N02CC06

ATC

eletriptan; oral

1.6

16.6

339

2077

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

3.3

16.6

190

UJF30

NOMESCO Finland

Ileoscopy through colon

1.3

16.6

1373

10856

K02.2

ICD-10 Finland

Caries of cementum

1.4

16.6

618

4318

R81

ICPC

Pneumonia

1.5

16.6

474

3141

A02BA04

ATC

nizatidine; systemic

1.3

16.5

1079

8261

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

1.9

16.5

218

1179

J01CE02

ATC

phenoxymethylpenicillin; oral

1.1

16.5

10253

96498

SPAT1283

SPAT

Restricted health certificate

1.3

16.5

1651

13358

SPAT1304

SPAT

Counselling and guidance related to ageing

1.3

16.5

1116

8591

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.2

16.5

1928

15876

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

3.2

16.4

196

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.3

16.3

1547

12434

K02.0

ICD-10 Finland

Caries limited to enamel

1.2

16.3

2015

16684

29540

ICD-8 Finland

Acute schizophrenia episode

4.0

16.3

112

R06AX22

ATC

ebastine; oral

1.2

16.3

2147

17899

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

3.9

16.3

121

G43.8

ICD-10 Finland

Other migraine

2.1

16.3

156

756

R01AD05

ATC

budesonide; nasal

1.3

16.3

946

7122

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

2.4

16.2

105

432

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

2.4

16.2

113

481

TJD20

NOMESCO Finland

Change of gastrostomy tube

3.1

16.2

208

J02AC02

ATC

itraconazole; systemic

1.2

16.2

2373

19999

L18

ICPC

Muscle pain

1.5

16.2

511

3458

K29.7

ICD-10 Finland

Gastritis, unspecified

1.5

16.1

483

3232

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

1.8

16.1

252

1436

F29

ICPC

Eye symptom/complaint other

1.3

16.1

1229

9614

IER03

NOMESCO Finland

Psychiatric disorder-specific group intervention

4.4

16.1

SPAT1106

SPAT

Acupuncture

2.4

16.1

107

446

N05AL05

ATC

amisulpride; oral

7.1

16.1

G11.9

ICD-10 Finland

Hereditary ataxia, unspecified

4.5

16.1

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

3.7

16.0

136

359

Kela drug reimbursment

Mirabegroni

2.5

16.0

387

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.3

16.0

1426

11376

2962C

ICD-9 Finland

Affective psychoses, Major depressive disorder, single episode[PSYCHOSIS BIPOLARIS MANICA,KESKIVAIKEA]

6.0

16.0

F25.80

ICD-10 Finland

Other specified schizoaffective disorder with only concomitant bipolar and schizophrenic symptoms

6.0

16.0

M70.7

ICD-10 Finland

Other bursitis of hip

1.6

16.0

348

2166

B35.1

ICD-10 Finland

Tinea unguium

1.4

16.0

807

5944

H57.1

ICD-10 Finland

Ocular pain

1.5

16.0

421

2741

F60.8

ICD-10 Finland

Other specific personality disorders

2.9

15.9

263

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.6

15.9

325

1991

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.3

15.9

1638

13293

AA1CG, ,

SPAT

2.2

15.9

130

592

W10

ICD-10 Finland

Fall on and from stairs and steps

1.4

15.9

669

4781

2954A

ICD-9 Finland

Schizophrenic psychoses, Acute schizophrenic episode

3.5

15.8

156

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.7

15.8

286

1697

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

15.8

3102

26841

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

15.8

5331

48119

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.4

15.8

872

6512

F10.24

ICD-10 Finland

Alcohol depence active use

2.0

15.8

166

832

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

15.8

1665

13548

T08

ICPC

Weight loss

1.8

15.8

213

1161

R25

ICD-10 Finland

Abnormal involuntary movements

12.2

15.8

M01AX05

ATC

glucosamine; oral

1.2

15.8

3011

25995

K07.4

ICD-10 Finland

Malocclusion, unspecified

1.9

15.7

187

979

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.3

15.7

1025

7849

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.3

15.7

1147

8921

S01.41

ICD-10 Finland

Open wound in the temple-jaw region

2.2

15.7

135

628

RF120, ,

NOMESCO Finland

2.1

15.7

153

747

R68.2

ICD-10 Finland

Dry mouth, unspecified

2.3

15.7

110

470

SPAT1285

SPAT

Provision of consultation response

1.4

15.6

716

5189

UJH02

NOMESCO Finland

Anoscopy

1.5

15.6

534

3670

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

1.8

15.6

218

1201

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

1.7

15.6

312

1903

XCK00

NOMESCO Finland

Perimetry

1.3

15.6

894

6719

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.8

15.5

218

1203

H02AB07

ATC

prednisone; oral

1.2

15.5

1940

16085

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

2.2

15.5

125

567

B37.0

ICD-10 Finland

Candidal stomatitis

2.1

15.4

150

731

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.1

15.4

150

732

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.4

15.3

620

4398

G01AF05

ATC

econazole; vaginal

1.4

15.3

859

6432

30088

ICD-8 Finland

Neuroses, Other

2.8

15.3

258

Z91.5

ICD-10 Finland

Personal history of self-harm

4.1

15.3

100

S02

ICPC

Pruritus

1.5

15.3

439

2912

F20.6

ICD-10 Finland

Simple schizophrenia

5.2

15.3

A69

ICPC

General and Unspecified, Other reason for encounter NEC

1.6

15.3

372

2379

2951E

ICD-9 Finland

Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]

6.7

15.3

29520

ICD-8 Finland

Schizophrenia, Catatonic type

5.9

15.2

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

2.0

15.2

155

769

SPAT1227

SPAT

Substance abuse rehabilitation

2.7

15.2

287

R07.2

ICD-10 Finland

Precordial pain

1.7

15.2

284

1702

AA1AM

NOMESCO Finland

Short MRI examination of brain with 3 Tesla magnet

4.1

15.1

101

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.4

15.1

571

4003

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

1.7

15.1

256

1495

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.4

15.0

829

6191

WYA30, ,

SPAT

2.4

15.0

411

X84

ICD-10 Finland

Intentional self-harm by unspecified means

4.1

15.0

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

1.5

15.0

409

2682

ZXA05

NOMESCO Finland

Left side

1.2

15.0

3729

32882

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.3

15.0

1154

9036

E87.6

ICD-10 Finland

Hypokalaemia

1.5

15.0

450

3013

M43.6

ICD-10 Finland

Torticollis

2.5

15.0

376

S10

ICPC

Boil/carbuncle

1.4

14.9

722

5281

S16

ICPC

Bruise/contusion

1.5

14.9

415

2735

OAB44, ,

SPAT

1.3

14.9

867

6528

M01AB55

ATC

diclofenac, combinations; oral

1.3

14.9

941

7171

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.3

14.9

1091

8488

IAB12

NOMESCO Finland

Psychiatric psychosis consultation

5.8

14.9

F20.32

ICD-10 Finland

Undifferentiated schizophrenia stable periodically

4.7

14.9

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

14.9

1332

10631

R52.0

ICD-10 Finland

Acute pain

1.6

14.9

385

2497

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.5

14.9

523

3615

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.2

14.9

2011

16802

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

2.6

14.9

336

C10AA01

ATC

simvastatin; oral

1.1

14.8

6998

64533

T05

ICPC

Feeding problem of adult

2.4

14.8

102

432

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

1.7

14.8

257

1510

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.4

14.8

103

439

EB1VA, ,

NOMESCO Finland

1.3

14.8

1511

12253

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.3

14.8

1002

7716

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.3

14.7

1154

9057

S01.9

ICD-10 Finland

Open wound of head, part unspecified

1.8

14.7

221

1245

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.4

14.7

626

4480

XF404

NOMESCO Finland

Ambulatory ECG

1.3

14.7

1242

9840

S09.9

ICD-10 Finland

Unspecified injury of head

1.9

14.7

189

1015

F84.5

ICD-10 Finland

Asperger syndrome

3.3

14.7

169

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.3

14.7

934

7126

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.6

14.7

325

2033

WVA20, ,

SPAT

1.6

14.6

319

1988

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.3

14.6

1062

8254

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

1.9

14.6

181

962

A85

ICPC

Adverse effect medical agent

2.1

14.5

142

694

OAB73, ,

SPAT

3.5

14.5

136

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

1.8

14.5

208

1157

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.6

14.5

190

3381

K44

ICD-10 Finland

Diaphragmatic hernia

2.1

14.4

130

616

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.2

14.4

3235

28283

30099

ICD-8 Finland

Neuroses, Unspecified neurosis

3.7

14.4

118

T82

ICPC

Obesity

1.5

14.4

425

2837

2953C

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN]

4.1

14.4

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.0

14.4

153

772

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.2

14.3

2441

20844

J34.2

ICD-10 Finland

Deviated nasal septum

1.4

14.3

603

4309

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.0

14.3

146

725

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.2

14.3

2760

23829

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.1

14.3

6597

60708

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.2

14.3

1541

12569

-, ,

ICD-10 Finland

1.6

14.3

304

1884

IAB08

NOMESCO Finland

Consultation concerning a patient who has attempted suicide

4.3

14.2

G50.0

ICD-10 Finland

Trigeminal neuralgia

1.8

14.2

218

1236

SPAT1051

SPAT

Guidance regarding sleep disorders

1.9

14.2

188

1019

VALMI, ,

NOMESCO Finland

1.2

14.2

3053

26594

R06AX13

ATC

loratadine; oral

1.2

14.2

1796

14900

M76.0

ICD-10 Finland

Gluteal tendinitis

1.7

14.2

253

1497

S06

ICPC

Rash localized

1.4

14.2

743

5505

97010

ICD-8 Finland

Adverse effect of psychotherapeutics, Tranquillisers

3.0

14.2

209

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

1.8

14.2

202

1121

DHB50

NOMESCO Finland

Turbinoplasty

1.7

14.2

277

1680

K56.2

ICD-10 Finland

Volvulus

2.3

14.1

103

448

S00.8

ICD-10 Finland

Superficial injury of other parts of head

1.8

14.1

220

1254

R03AC13

ATC

formoterol; inhalant

1.4

14.1

649

4710

ZYC02, ,

SPAT

1.9

14.1

168

881

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

3.0

14.0

200

SPAT1210

SPAT

Application of cast or individual aid

1.4

14.0

513

3575

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.4

14.0

593

4243

M02AA15

ATC

diclofenac; topical

1.3

14.0

975

7535

EB1MA

NOMESCO Finland

Cephalometry with X-ray

1.8

14.0

193

1061

Z3229

NOMESCO Finland

Other healthcare associate professional

1.3

14.0

1154

9119

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

4.8

14.0

H82

ICPC

Vertiginous syndrome

1.7

14.0

236

1377

F23.90

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

3.5

14.0

135

J01FF01

ATC

clindamycin; systemic

1.2

13.9

3816

33873

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.4

13.9

720

5325

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

2.4

13.9

365

N02CD02

ATC

galcanezumab; parenteral

3.4

13.9

145

71720

ICD-8 Finland

Other nonarticular rheumatism, Torticollis not specified as congential, pyschogenic or traumatic

5.2

13.9

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.5

13.8

498

3460

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

3.8

13.8

108

Z03

ICPC

Housing/neighbourhood problem

2.4

13.8

391

SXC05

NOMESCO Finland

Other oral or dental procedure

1.4

13.8

717

5308

P50

ICPC

Psychological, Medication/prescr/renewal

3.0

13.7

197

F30.1

ICD-10 Finland

Mania without psychotic symptoms

4.7

13.7

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.3

13.7

1341

10817

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.4

13.7

511

3574

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

2.4

13.7

362

R29

ICPC

Respiratory symptom/complaint other

1.3

13.7

829

6281

2988A

ICD-9 Finland

Other nonorganic psychoses, Other and unspecified reactive psychosis

3.5

13.7

132

M05BA04

ATC

alendronic acid; oral

1.3

13.7

1265

10137

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.3

13.7

881

6736

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

1.6

13.7

286

1766

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.3

13.6

1127

8907

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

1.8

13.6

190

1048

K07.62

ICD-10 Finland

Habitual dislocation of the jaw joint

2.5

13.6

327

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.6

13.6

337

2165

H29

ICPC

Ear symptom/complaint other

1.2

13.6

1568

12879

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

13.6

3154

27634

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.5

13.6

436

2961

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.3

13.6

1033

8076

K88

ICPC

Postural hypotension

2.1

13.6

130

631

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

2.9

13.6

209

IEY19

NOMESCO Finland

Psychiatric health counselling and guidance

4.2

13.6

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.3

13.6

1340

10820

AAG99

NOMESCO Finland

Other stereotactic intracranial operation

75.2

13.6

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

2.4

13.6

394

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

13.6

2725

23601

WX110, ,

SPAT

1.4

13.6

667

4895

K11.70

ICD-10 Finland

Hypoptyalism

2.4

13.5

382

ZXE20

NOMESCO Finland

More than three and less than five hours

1.2

13.5

1876

15706

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.3

13.5

419

34209, ,

ICD-8 Finland

+∞

13.5

F023, G20,

ICD-10 Finland

+∞

13.5

G25.4

ICD-10 Finland

Drug-induced chorea

+∞

13.5

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

1.5

13.5

369

2424

N06DA02

ATC

donepezil; oral

1.3

13.5

873

6677

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.3

13.5

1087

8564

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

2.2

13.5

112

515

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.3

13.5

993

7733

G22

ICD-10 Finland

Parkinsonism in diseases classified elsewhere

140.1

13.4

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

2.9

13.4

205

WX212

NOMESCO Finland

Femoral plexus blockade

1.6

13.4

311

1968

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.3

13.4

1086

8561

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.2

13.4

1512

12392

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

1.7

13.4

234

1379

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.5

13.4

462

3185

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

3.1

13.4

169

ICZ04

NOMESCO Finland

Preparation of psychiatric treatment plan

4.3

13.3

H02

ICPC

Hearing complaint

1.2

13.3

2041

17254

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.3

13.3

792

5986

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.1

13.3

5338

48629

R05FA02

ATC

opium derivatives and expectorants; systemic

1.1

13.3

5822

53334

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.2

13.3

1692

14045

D01AE16

ATC

amorolfine; topical

1.2

13.3

1628

13460

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

4.3

13.3

N48.1

ICD-10 Finland

Balanoposthitis

1.6

13.3

289

1802

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

3.5

13.3

130

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.4

13.2

535

3797

-1, ,

ICPC

1.4

13.2

481

3349

A01AB10

ATC

natamycin; local oral

1.5

13.2

360

2364

KED22

NOMESCO Finland

Transurethral resection of prostate

1.3

13.2

803

6088

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

3.2

13.2

160

A03BA03

ATC

hyoscyamine; oral

2.1

13.2

119

565

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

1.6

13.2

297

1867

T83

ICPC

Overweight

1.7

13.2

223

1302

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.5

13.2

462

3194

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

13.2

520

3675

D02

ICPC

Abdominal pain epigastric

1.3

13.2

739

5536

AXX01, ,

SPAT

1.5

13.1

409

2763

RT250, ,

NOMESCO Finland

3.9

13.1

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

3.1

13.1

171

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

2.5

13.1

304

TNX00, ,

SPAT

2.0

13.1

132

654

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.2

13.1

2081

17653

S92.3

ICD-10 Finland

Fracture of metatarsal bone

1.5

13.1

380

2531

SPAT1042

SPAT

Guidance concerning balance maintenance

2.5

13.1

334

R20.8

ICD-10 Finland

Other and unspecified disturbances of skin sensation

2.1

13.0

127

621

P77

ICPC

Suicide/suicide attempt

4.6

13.0

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

3.6

13.0

113

A60

ICPC

General and Unspecified, Result test/procedure

1.4

12.9

558

4007

OAB42, ,

SPAT

1.3

12.9

1215

9754

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

3.6

12.9

118

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.6

12.9

264

4193

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

2.1

12.9

117

557

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.2

12.9

2129

18121

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.4

12.9

490

3441

H25.1

ICD-10 Finland

Senile nuclear cataract

1.1

12.8

4458

40212

M01AB08

ATC

etodolac; oral

1.3

12.8

900

6965

R1430, ,

SPAT

2.1

12.8

113

533

EB1AA, ,

SPAT

1.3

12.8

769

5823

J01AA07

ATC

tetracycline; systemic

1.2

12.8

1728

14432

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.2

12.7

3653

32508

K58

ICD-10 Finland

Irritable bowel syndrome

1.6

12.7

278

1735

TAC00

NOMESCO Finland

Peripheral nerve block

2.8

12.7

228

ZXY03

NOMESCO Finland

Occupational therapist

3.6

12.7

110

N06AA22, ,

ATC

2.3

12.7

394

H81.3

ICD-10 Finland

Other peripheral vertigo

1.5

12.7

359

2379

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.6

12.6

289

1824

D06AX01

ATC

fusidic acid; topical

1.3

12.6

1154

9232

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

1.5

12.6

349

2299

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.4

12.6

605

4422

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

1.9

12.6

162

872

H26.4

ICD-10 Finland

After-cataract

1.2

12.6

1509

12447

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.4

12.6

596

4348

N02CA01

ATC

dihydroergotamine; nasal, systemic

2.7

12.6

235

A02BX02

ATC

sucralfate; oral

1.4

12.6

529

3783

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

3.0

12.6

186

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.6

12.6

260

1602

C01CA24

ATC

epinephrine; parenteral

1.4

12.6

651

4819

K04

ICPC

Palpitations/awareness of heart

1.4

12.5

658

4880

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

1.7

12.5

223

1321

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.3

12.5

1206

9709

J01DA09

ATC

[U] cefadroxil

1.2

12.5

3587

31913

F30.9

ICD-10 Finland

Manic episode, unspecified

3.3

12.5

140

C10AA05

ATC

atorvastatin; oral

1.1

12.5

6607

61157

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

4.1

12.5

N03AX18

ATC

lacosamide; systemic

2.3

12.5

415

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.4

12.5

459

3203

F20.12

ICD-10 Finland

Hebefren schizophrenia stable periodically

17.3

12.5

R19.5

ICD-10 Finland

Other faecal abnormalities

1.7

12.4

204

1182

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

2.3

12.4

379

D03

ICPC

Heartburn

1.5

12.4

411

2812

F32.0

ICD-10 Finland

Mild depressive episode

1.6

12.4

274

1716

F20.4

ICD-10 Finland

Post-schizophrenic depression

5.6

12.4

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.3

12.4

1186

9542

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

1.9

12.4

159

856

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.5

12.4

392

2659

A09

ICPC

Sweating problem

1.9

12.4

142

737

TED00

NOMESCO Finland

Closed reduction of dislocation of jaw

4.8

12.3

G56.3

ICD-10 Finland

Lesion of radial nerve

2.2

12.3

102

469

TJD10

NOMESCO Finland

Insertion of other tube into stomach or duodenum

3.8

12.3

29899

ICD-8 Finland

Other psychoses, Reactive psychosis, unspecified

4.1

12.3

G40

ICD-10 Finland

Epilepsy

2.1

12.3

108

509

L03.9

ICD-10 Finland

Cellulitis, unspecified

1.6

12.2

255

1574

D25

ICPC

Abdominal distension

1.7

12.2

225

1345

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.3

12.2

793

6069

G03DB01

ATC

dydrogesterone; oral

1.2

12.2

1336

10913

SPAT1293

SPAT

Other function in accordance with rehabilitation guidance nomenclature

2.4

12.2

345

X14

ICPC

Vaginal discharge

1.8

12.2

181

1019

G31.0

ICD-10 Finland

Circumscribed brain atrophy

2.5

12.2

309

SPAT1138

SPAT

Guidance concerning bowel function

1.7

12.2

194

1115

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.4

12.2

574

4186

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

2.8

12.1

206

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

3.8

12.1

H51.1

ICD-10 Finland

Convergence insufficiency and excess

3.3

12.1

133

C08CA05

ATC

nifedipine; systemic

1.3

12.1

863

6691

F50.9

ICD-10 Finland

Eating disorder, unspecified

2.5

12.1

298

D01AC02

ATC

miconazole; topical

1.3

12.1

1011

8002

NB6AA

NOMESCO Finland

Humerus X-ray examination

1.6

12.1

276

1742

XJH00

NOMESCO Finland

Transanal ultrasonography

1.3

12.1

852

6596

SPAT1238

SPAT

Brief therapy

1.8

12.1

162

884

Y94.0

ICD-10 Finland

Accident at home

1.6

12.1

240

1464

A02BA03

ATC

famotidine; systemic

1.4

12.1

501

3574

RF210, ,

NOMESCO Finland

1.5

12.1

328

2154

XG474

NOMESCO Finland

Exhalation nntrogen oxide

1.6

12.1

281

1782

A07DA03

ATC

loperamide; oral

1.4

12.1

442

3083

F05

ICPC

Visual disturbance other

1.5

12.1

373

2517

R40.2

ICD-10 Finland

Coma, unspecified

2.1

12.1

117

572

SPAT1336

SPAT

Request for examination

1.4

12.1

460

3233

M75

ICD-10 Finland

Shoulder lesions

1.4

12.0

527

3795

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.5

12.0

390

2657

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.2

12.0

2770

24243

30041

ICD-8 Finland

Neuroses, Depressiva

1.8

12.0

165

908

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

1.9

12.0

144

759

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.4

12.0

504

3605

F06.7

ICD-10 Finland

Mild cognitive disorder

1.5

12.0

407

2799

I50

ICD-10 Finland

Heart failure

1.4

12.0

446

3121

XA400

NOMESCO Finland

EEG

2.4

12.0

348

M15

ICD-10 Finland

Polyarthrosis

1.3

12.0

673

5046

F60.2

ICD-10 Finland

Dissocial personality disorder

3.9

12.0

R2130, ,

SPAT

1.9

12.0

152

816

RF214, ,

NOMESCO Finland

4.2

12.0

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

4.2

12.0

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.3

11.9

1223

F80.1

ICD-10 Finland

Expressive language disorder

2.2

11.9

102

475

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.2

11.9

2692

23516

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.2

11.9

1264

10289

IEY05, ,

SPAT

5.0

11.9

NA1BM

NOMESCO Finland

Cervical spine MRI examination with 3 Tesla magnet

3.7

11.9

101

7804A

ICD-9 Finland

General symptoms, Dizziness and giddiness

1.8

11.9

174

976

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.5

11.9

376

2551

29550

ICD-8 Finland

Latent schizophrenia

4.7

11.9

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

2.6

11.8

260

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

2.8

11.8

209

K29

ICPC

Cardiovascular sympt/complt other

1.4

11.8

597

4402

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

2.6

11.8

243

SPAT1043

SPAT

Audiometry

1.2

11.8

1480

12263

SAA04

NOMESCO Finland

Special examination of mouth

1.4

11.8

606

4481

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.3

11.7

757

5790

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

3.6

11.7

102

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

4.2

11.7

L11

ICPC

Wrist symptom/complaint

1.3

11.7

1040

8295

M41.4

ICD-10 Finland

Neuromuscular scoliosis

9.6

11.7

ZXY83

NOMESCO Finland

Social worker in multidisciplinary team

3.8

11.7

WZC30, ,

SPAT

1.3

11.7

682

5142

C01DA14

ATC

isosorbide mononitrate; oral

1.2

11.7

2463

21397

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

3.6

11.7

107

P58

ICPC

Psychological, Therapeutic counselling/listening

1.8

11.7

169

945

K27

ICPC

Fear cardiovascular disease other

1.9

11.7

134

696

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.5

11.6

385

2634

RF420, ,

NOMESCO Finland

1.8

11.6

165

917

IEY19, ,

SPAT

4.6

11.6

X78

ICD-10 Finland

Intentional self-harm by sharp object

2.7

11.6

217

M99.3

ICD-10 Finland

Osseous stenosis of neural canal

2.6

11.6

257

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.3

11.6

707

5368

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.4

11.6

546

3984

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.4

11.5

484

3461

B35.3

ICD-10 Finland

Tinea pedis

1.4

11.5

516

3731

D07AB08

ATC

desonide; topical

1.2

11.5

1375

11336

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.3

11.5

830

6449

K05.1

ICD-10 Finland

Chronic gingivitis

1.3

11.5

793

6124

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

3.1

11.5

148

ECB00

NOMESCO Finland

Suture of gingiva

1.4

11.5

439

3089

R03BC03

ATC

nedocromil; inhalant

1.3

11.5

854

6663

T90

ICPC

Diabetes non-insulin dependent

1.1

11.4

3520

31454

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.2

11.4

1327

10909

L95

ICPC

Osteoporosis

1.4

11.4

483

3460

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

2.2

11.4

400

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.6

11.4

207

3377

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

1.6

11.4

240

1487

F51.1

ICD-10 Finland

Nonorganic hypersomnia

4.5

11.4

2956C

ICD-9 Finland

Schizophrenic psychoses, Residual schizophrenia[RESIDUAALINEN SKITSOFRENIA,KROONINEN]

4.5

11.4

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.3

11.4

922

7270

IAZ99, ,

SPAT

4.6

11.4

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.5

11.4

327

2175

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

1.9

11.3

134

703

F23.8

ICD-10 Finland

Other acute and transient psychotic disorders

3.4

11.3

119

ZZH40

NOMESCO Finland

Substitute of bone

2.0

11.3

118

593

R07.0

ICD-10 Finland

Pain in throat

1.3

11.3

749

5752

R39.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the urinary system

2.1

11.3

107

519

CBJ50

NOMESCO Finland

Operation for ptosis of eyebrow

2.1

11.3

100

473

T78.4

ICD-10 Finland

Allergy, unspecified

1.4

11.3

486

3493

ZXD05

NOMESCO Finland

Urgent procedure

1.1

11.3

4297

38942

F0029, G308,

ICD-10 Finland

3.7

11.3

F70.1

ICD-10 Finland

Mild mental retardation, Significant impairment of behaviour requiring attention or treatment

4.2

11.2

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

2.7

11.2

215

B07.9

ICD-10 Finland

Verruca simplex

1.5

11.2

392

2711

RS230, ,

NOMESCO Finland

2.5

11.2

267

SPE90

NOMESCO Finland

Other partial denture

1.6

11.2

278

1790

UJD10, ,

SPAT

1.6

11.2

265

1688

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.5

11.2

327

2182

TCA20

NOMESCO Finland

Peribulbar therapeutic injection into orbit

3.4

11.2

115

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

2.2

11.2

416

Z30.0

ICD-10 Finland

General counselling and advice on contraception

1.5

11.2

374

2566

RS140, ,

NOMESCO Finland

4.0

11.2

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.3

11.2

669

5065

M01AX01

ATC

nabumetone; oral

1.4

11.1

537

3932

S62.3

ICD-10 Finland

Fracture of other metacarpal bone

1.5

11.1

298

1953

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

1.7

11.1

210

1266

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

10695

80101

1.79

312.45

6.1

6.7

1.22

1.21

mmol/l

3.35

9162

67544

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

9413

66089

1.86

307.65

2.3

2.0

94.16

95.26

pmol/l

1.41

5179

34142

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

7464

47993

1.93

307.65

2.5

2.1

210.99

213.46

u/l

0.07

7012

44804

(3001122) Ferritin [Mass/volume] in Serum or Plasma

9150

63110

1.89

307.65

3.2

2.9

118.34

141.68

ug/l

16.04

8306

57820

(3021960) Folate [Moles/volume] in Serum or Plasma

5934

37919

1.83

291.00

1.6

19.94

20.39

nmol/l

1.02

5138

32155

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

9819

72692

1.75

289.01

5.6

6.0

1.21

mmol/l

1.71

8948

65855

(3009466) Valproate [Moles/volume] in Serum or Plasma

760

1855

4.23

278.74

6.2

4.4

386.83

355.24

umol/l

6.73

689

1546

(3019309) Folate [Moles/volume] in Red Blood Cells

5047

31694

1.81

255.65

1.9

1.8

1199.01

1159.61

nmol/l

2.07

3828

23631

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

13729

114429

1.77

240.07

4.7

4.0

14.98

14.89

pmol/l

3.86

12477

103007

(3031040) Bacteria [#/volume] in Urine by Automated count

12582

102798

1.70

231.39

6.1

4.7

1755.17

1531.92

e6/l

0.16

197

1516

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5946

40367

1.70

222.64

2.4

2.3

2.86

3.03

mg/l

6.55

4990

34328

(3013707) Erythrocyte sedimentation rate by Westergren method

13493

112819

1.72

222.52

4.5

4.2

11.87

13.24

mm/h

24.84

12459

103775

(3015377) Calcium [Moles/volume] in Serum or Plasma

7418

53607

1.64

216.44

2.7

3.4

2.35

mmol/l

1.71

6410

46572

(3018418) pH of Serum or Plasma

6665

47674

1.62

197.66

3.6

4.1

7.40

0.72

1151

9135

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

15631

137809

1.86

197.48

5.9

4.8

1.87

2.10

mu/l

5.99

14384

124985

(3024666) Lithium [Moles/volume] in Serum or Plasma

346

578

6.08

196.91

14.1

11.6

0.65

0.62

mmol/l

0.76

315

522

(3037467) Urinalysis macro (dipstick) panel - Urine

12679

106125

1.62

188.60

5.3

4.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

8930

69231

1.56

182.95

4.2

4.8

35.52

35.09

g/l

10.71

8254

64026

(3026008) Bacteria identified in Urine by Culture

6871

50200

1.59

182.50

3.8

3.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

13839

119030

1.64

177.43

7.1

7.7

77.37

79.47

u/l

6.23

13022

111829

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4998

34075

1.64

175.35

1.7

21347656.47

31489797.22

pmol/l

0.78

4127

27730

(3013826) Glucose [Moles/volume] in Serum or Plasma

11190

91881

1.55

172.26

5.0

4.7

6.62

6.79

mmol/l

13.68

10592

86199

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

316

573

5.59

165.02

16.7

17.2

1446.20

3113.32

nmol/l

0.50

305

552

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8214

63469

1.53

164.32

2.4

2.2

77.79

1537.20

nmol/l

0.50

7286

56212

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

299

554

5.47

152.53

11.9

12.3

839.58

850.82

nmol/l

0.12

286

533

(40760892) CBC W Ordered Manual Differential panel - Blood

8974

71381

1.50

151.78

6.3

6.4

—

(3006315) Basophils [#/volume] in Blood

9450

76110

1.49

149.35

6.0

5.8

0.04

e9/l

5.20

8153

65272

(3013115) Eosinophils [#/volume] in Blood

9694

78547

1.49

148.23

6.5

6.0

0.19

0.20

e9/l

4.41

8497

68277

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

7837

60847

1.50

147.83

4.5

3.8

101.53

66.62

ng/l

0.28

5760

43734

(3001604) Monocytes [#/volume] in Blood

9414

75906

1.49

146.96

6.0

5.8

0.58

0.60

e9/l

15.24

8141

65113

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

861

3351

2.65

146.79

1.3

536.71

537.95

mg/l

0.01

809

3183

(3035350) Ketones [Presence] in Urine by Test strip

9281

74955

1.48

141.48

4.6

3.8

0.00

estimate

5.04

1819

15052

(3019198) Lymphocytes [#/volume] in Blood

9585

77910

1.48

141.36

6.2

5.9

1.90

1.91

e9/l

0.13

8449

68346

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3849

25782

1.62

139.85

2.6

3.3

0.83

0.81

mmol/l

7.70

3511

23976

(3015736) pH of Urine

7719

60254

1.48

138.88

4.2

3.5

5.90

5.86

0.42

388

3608

(3021601) Nitrite [Presence] in Urine by Test strip

9228

74918

1.46

133.88

6.0

5.1

0.00

estimate

2.09

1734

14034

(3009261) Glucose [Presence] in Urine by Test strip

9307

75769

1.46

132.53

4.7

3.8

0.00

estimate

0.09

1703

13719

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

762

2940

2.66

132.02

1.2

1.3

3.85

3.79

mmol/l

0.76

708

2757

(3013650) Neutrophils [#/volume] in Blood by Automated count

10551

88080

1.46

131.00

9.2

9.0

4.17

4.18

e9/l

0.32

9227

76481

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

747

2934

2.61

124.78

1.3

1.4

7.39

30.08

e6/l

3.66

551

2283

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

747

2935

2.61

124.69

1.4

1.5

538.71

3306.88

e6/l

1.25

592

2408

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3843

26359

1.58

124.34

2.0

1.9

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4281

30091

1.55

124.29

2.7

3.1

2.44

2.46

mmol/l

14.02

3739

26206

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

6374

49206

1.45

114.83

2.6

55.03

63.53

u/l

3.95

5844

45254

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

16259

150085

1.68

112.41

18.9

15.5

23.20

24.89

mg/l

9.27

13648

120685

(3022948) Iron [Moles/volume] in Serum or Plasma

3683

25521

1.55

112.34

2.3

2.5

13.25

12.59

umol/l

6.08

3345

23650

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

353

955

3.75

111.76

1.1

282.50

291.77

mg/l

1.56

321

849

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4283

30767

1.51

110.21

1.3

1.67

u/ml

0.01

1085

8023

(3023368) Bacteria identified in Blood by Culture

5814

44423

1.45

109.28

4.5

4.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

9754

81713

1.41

109.24

5.1

6.2

10.91

11.65

umol/l

7.28

9193

77397

(3044290) Cell count panel - Cerebral spinal fluid

680

2724

2.55

108.93

1.3

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

4859

35956

1.48

107.53

4.5

3.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2760

18095

1.62

106.10

1.9

1.8

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2176

13433

1.70

105.76

2.1

2.2

377.09

376.41

nmol/l

0.05

1983

12276

(3019550) Sodium [Moles/volume] in Serum or Plasma

16685

155636

1.72

103.91

22.0

18.0

139.66

139.63

mmol/l

0.86

16367

151600

(3018095) Leukocytes [#/volume] in Urine

7029

55977

1.41

103.54

4.3

3.8

104.12

105.02

e6/l

0.02

5158

39991

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

202

373

5.46

103.48

3.0

2.2

149.34

150.11

nmol/l

0.03

175

321

(36304419) Bacteria [Presence] in Urine

5615

42972

1.44

103.24

3.5

3.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

16704

155987

1.72

101.96

22.1

18.1

3.97

3.98

mmol/l

2.80

16366

151675

(3019150) Specific gravity of Urine by Refractometry

4471

32883

1.47

100.89

5.2

4.3

1.02

kg/l

0.28

660

5150

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2737

18133

1.60

100.20

1.9

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4492

33120

1.47

99.91

1.8

1.7

1.17

1.32

mg/l

2.30

3401

25556

(3030467) Casts [#/volume] in Urine by Automated count

5767

44558

1.43

99.84

3.6

3.2

0.33

0.45

e6/l

6.95

4505

34094

(3022096) Basophils/100 leukocytes in Blood

8391

69223

1.39

98.81

6.1

0.66

0.67

1.32

7770

64145

(3006504) Eosinophils/100 leukocytes in Blood

8612

71405

1.39

98.08

6.1

2.80

2.85

1.55

7987

66292

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2352

15091

1.64

98.01

1.9

1.7

1.51

1.49

0.74

2053

12977

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1652

9642

1.78

97.55

2.5

2.4

27.10

23.40

au/ml

0.51

663

(3019069) Monocytes/100 leukocytes in Blood

8648

71813

1.38

97.26

6.4

8.50

8.69

7.14

8024

66793

(3018010) Neutrophils/100 leukocytes in Blood

8696

72289

1.38

97.10

6.1

5.9

57.97

57.80

0.66

8079

67317

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

10984

94945

1.39

96.03

3.6

3.1

46.46

50.80

u/l

5.04

10153

87508

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3374

23658

1.52

95.44

2.3

2.5

2.35

2.30

g/l

5.77

3043

21796

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1526

8758

1.81

95.26

1.3

62.14

54.91

au/ml

0.45

470

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

180

325

5.58

94.50

1.6

1.2

112.67

133.87

nmol/l

0.85

117

241

(3002030) Lymphocytes/100 leukocytes in Blood

8789

73480

1.37

93.24

6.3

6.2

27.14

27.15

0.05

8168

68489

(3022217) INR in Platelet poor plasma by Coagulation assay

9071

76224

1.37

93.20

16.6

1.25

1.31

inr

6.71

2546

21634

(3002582) Erythrocytes [#/volume] in Urine

6137

48546

1.39

90.57

3.7

3.3

69.75

101.77

e6/l

1.39

4804

37340

(3028707) Methadone [Presence] in Urine by Screen method

425

1476

2.92

89.78

2.8

2.6

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

284

802

3.58

84.43

1.1

5.92

7.00

nmol/l

0.10

172

(3000850) Epithelial cells [#/volume] in Urine

4475

33935

1.42

82.77

2.8

2.6

5.43

5.38

e6/l

0.06

4028

30348

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

6088

48650

1.37

82.42

3.0

3.1

1231.42

1585.72

ng/l

7.98

5176

41944

(3029937) Albumin [Presence] in Urine by Test strip

5223

40782

1.39

81.19

5.3

4.2

0.00

estimate

0.35

1676

13430

(3001186) Copper [Moles/volume] in Serum or Plasma

156

285

5.51

80.91

1.1

1.4

16.36

17.17

umol/l

1.08

140

256

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6994

57352

1.35

79.44

5.1

4.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3106

22291

1.47

76.37

2.4

2.6

22.56

22.07

1.12

2572

18902

(3007164) IgA [Mass/volume] in Serum or Plasma

3623

26973

1.43

72.82

1.4

1.5

2.28

2.52

g/l

9.67

2006

15876

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3687

27567

1.42

72.29

3.1

2.8

1.24

1.27

e6/l

0.08

2184

15828

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

14983

138800

1.42

71.26

6.6

6.1

39.92

40.20

mmol/mol

3.43

13789

127143

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1511

9395

1.66

69.92

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

9734

84893

1.31

67.64

3.0

2.7

—

(3016018) Differential panel - Cerebral spinal fluid

370

1412

2.65

65.38

1.3

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1536

9776

1.62

64.57

1.8

1.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

287

974

2.98

63.25

1.0

35.30

44.21

ng/l

2.63

188

662

(3023410) Appearance of Cerebral spinal fluid

346

1298

2.70

63.25

1.4

1.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

285

965

2.98

63.07

1.0

250.69

341.93

ng/l

8.54

196

666

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5895

48317

1.32

62.95

3.2

30.18

34.70

u/l

8.82

5504

45627

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

285

971

2.97

62.38

1.0

726.09

713.49

ng/l

0.17

188

648

(3033942) Copper [Moles/time] in 24 hour Urine

15.63

61.39

1.0

1.2

0.32

1.16

umol/24h

0.66

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

15520

145534

1.41

61.29

5.3

4.8

5.98

6.00

mmol/l

0.98

14098

131392

(40761535) Cells panel - Urine sediment

1949

13285

1.52

60.52

3.8

3.5

—

(40761511) CBC panel - Blood by Automated count

16313

154445

1.47

60.39

17.9

14.6

—

(3011288) Drugs identified in Urine by Screen method

491

2226

2.24

59.42

3.5

2.8

—

(3048689) Calprotectin [Mass/mass] in Stool

2367

16847

1.46

59.30

2.1

2.2

143.23

140.87

ug/g

0.10

1847

13142

(3003396) Base excess in Arterial blood by calculation

2592

18787

1.44

58.95

5.6

6.9

1.51

1.06

mmol/l

7.31

2113

14933

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

342

1324

2.61

58.74

1.1

71.32

73.24

au/ml

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

275

951

2.92

58.63

1.2

1.1

37.48

42.13

mg/l

0.96

225

799

(3027801) Oxygen [Partial pressure] in Arterial blood

2586

18783

1.44

58.07

5.6

6.9

11.68

12.23

kpa

6.43

2453

17867

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2587

18795

1.44

58.01

5.6

6.9

5.17

5.07

kpa

5.40

2463

17889

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

106

185

5.76

57.80

2.1

1.9

17.10

16.79

umol/l

0.09

106

185

(40768797) Stomach Pathology biopsy report

2890

21440

1.41

57.62

1.3

1.2

—

(3044889) 12 lead EKG panel

11840

107074

1.29

57.47

4.4

4.0

—

(40758558) Short blood count panel - Blood

4818

38837

1.33

56.48

6.7

6.9

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

264

912

2.92

56.40

1.1

253.63

278.82

mg/l

1.20

228

802

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

964

5617

1.76

56.33

2.1

2.3

600.68

594.58

ug/l

0.01

892

5286

(3019060) Gas panel - Arterial blood

1641

10975

1.54

55.38

4.2

4.7

—

(3026782) Osmolality of Urine

4099

32413

1.34

54.52

3.2

3.0

536.45

539.61

mosm/kgh2o

0.41

3478

27771

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

253

872

2.93

54.29

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3985

31426

1.34

53.88

4.3

3.9

235.72

472.80

ng/l

4.42

3105

25506

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1545

10263

1.55

53.70

6.3

7.0

25.19

24.54

mmol/l

10.06

1475

9774

(1001926) Buprenorphine [Presence] in Urine by Screen method

531

2595

2.08

53.08

2.6

2.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3252

25001

1.36

51.65

1.3

30.40

36.83

iu/ml

1.60

945

7986

(3016502) Oxygen saturation in Arterial blood

2316

16821

1.43

51.51

5.9

7.3

95.34

95.56

0.93

2221

16186

(3016879) Cocaine [Presence] in Urine

600

3136

1.94

49.65

2.6

2.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3300

25644

1.35

48.51

3.4

3.0

2.80

2.60

e6/l

0.52

1809

14015

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

211

706

3.01

47.79

1.7

1.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

16604

158835

1.44

47.35

11.8

10.8

23.98

25.71

u/l

23.46

15941

152637

(3000764) Benzodiazepines [Presence] in Urine

625

3372

1.88

46.98

2.6

2.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

294

1180

2.52

46.94

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

2602

19650

1.38

45.62

1.4

1.3

574.42

539.43

titre

0.35

513

4280

(3028300) Cannabinoids [Presence] in Urine

625

3407

1.86

45.49

2.6

2.0

—

(3027008) Opiates [Presence] in Urine

623

3399

1.86

45.22

2.6

1.9

—

(3023183) Ammonium ion [Moles/volume] in Plasma

595

3206

1.88

44.91

2.2

2.5

30.10

33.70

umol/l

3.93

530

2857

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2105

15377

1.42

44.89

6.2

7.7

122.39

120.53

g/l

4.08

2043

14961

(3020630) Protein [Mass/volume] in Serum or Plasma

1925

13871

1.43

44.27

2.0

2.6

66.59

66.23

g/l

1.31

1706

12495

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1343

9016

1.53

44.17

3.0

3.3

4.40

4.41

pmol/l

0.08

1153

7956

(3027945) Reticulocytes/100 erythrocytes in Blood

2510

18950

1.38

43.94

2.3

2.4

1.69

1.78

5.37

2138

16644

(36660697) Celiac disease serology panel - Serum

1583

11048

1.47

43.05

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

4790

39720

1.28

42.94

3.9

4.0

88.33

88.28

0.05

4648

38736

(3004588) Protein electrophoresis panel - Serum or Plasma

1635

11506

1.46

42.59

1.9

2.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1733

12358

1.44

42.07

3.2

3.8

84.18

92.61

ng/l

3.03

1467

10544

(3027944) Amphetamines [Presence] in Urine

603

3335

1.84

41.91

2.4

2.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

815

4926

1.68

41.55

3.9

4.3

3.86

3.89

mmol/l

1.05

809

4883

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3004

23505

1.33

41.37

1.3

9.15

14.02

u/ml

3.86

1113

8664

(1002224) Polysomnography panel

817

4960

1.68

40.95

1.1

—

(3051339) Copper [Moles/volume] in Blood

8.08

40.47

1.1

15.99

17.42

umol/l

1.84

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2602

20011

1.35

40.15

8.7

7.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1932

14180

1.40

39.80

5.5

6.7

1.32

1.37

mmol/l

1.16

1887

13755

(3018405) Lactate [Moles/volume] in Arterial blood

916

5771

1.62

39.66

3.8

4.1

1.29

1.39

mmol/l

2.27

903

5670

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1663

11925

1.43

39.03

1.7

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

14914

141177

1.29

38.83

16.8

14.6

79.43

77.70

ml/min/173m2

19.74

12558

116916

(3020891) Body temperature

1000

6482

1.57

38.39

4.9

4.8

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1474

10367

1.46

38.35

3.6

3.7

5.22

5.14

kpa

3.53

1384

9776

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3135

24919

1.31

38.27

1.9

2.1

29.74

29.92

0.89

3040

24169

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

257

1068

2.43

38.16

1.2

1.3

1.98

2.16

mmol/l

2.17

238

990

(3021589) Normoblasts [#/volume] in Blood

7572

66839

1.22

37.41

10.5

10.0

0.00

e9/l

0.33

6109

54638

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

298

1333

2.26

37.37

1.4

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

888

5635

1.60

37.30

1.2

0.93

0.98

u/ml

0.05

116

503

(3036180) Methadone [Presence] in Urine

140

426

3.30

37.30

2.1

2.7

—

(3009343) pH of Capillary blood

1452

10237

1.45

37.27

3.6

7.42

1.25

220

1323

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2701

21116

1.33

37.00

4.7

5.7

1.02

1.04

mmol/l

2.90

2473

19533

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1408

9884

1.46

36.95

3.6

2.02

1.80

mmol/l

1.42

1070

7285

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

217

4.30

36.32

1.0

—

(3019225) pH of Specimen

2154

16325

1.36

36.27

4.3

4.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

611

3565

1.74

35.43

1.8

1.7

318.27

300.83

mu/l

0.55

554

3246

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1907

14304

1.37

34.17

2.4

2.5

32.94

48.58

u/l

1.76

1601

12190

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

226

936

2.43

33.86

1.7

1.4

14.48

12.74

umol/l

2.76

219

874

(3009542) Hematocrit [Volume Fraction] of Blood

16994

164544

1.40

32.98

28.6

22.8

39.68

39.98

3.13

15826

152980

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1921

14506

1.36

32.92

2.6

2.4

5.39

7.06

ug/l

6.33

1570

12526

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

695

4282

1.65

32.88

1.2

—

(3000494) Fungus identified in Specimen by Culture

2294

17806

1.33

32.70

1.5

1.4

—

(3007461) Platelets [#/volume] in Blood

16993

164637

1.39

31.88

28.6

22.7

246.26

248.17

e9/l

3.53

16643

159896

(3014765) Yersinia sp identified in Stool by Organism specific culture

696

4329

1.63

31.71

1.2

—

(3035941) MCH [Entitic mass]

16994

164699

1.38

31.35

28.5

22.6

30.37

30.35

0.86

16784

162002

(42529406) Shigella sp [Presence] in Stool by Culture

696

4342

1.63

31.33

1.2

—

(3024731) MCV [Entitic volume]

16995

164716

1.38

31.29

28.5

22.6

91.45

91.29

5.23

16784

162018

(3026361) Erythrocytes [#/volume] in Blood

16995

164727

1.38

31.18

28.6

22.7

4.42

4.45

e12/l

13.19

16584

159422

(3000963) Hemoglobin [Mass/volume] in Blood

16997

164756

1.38

31.11

28.8

22.8

133.20

134.18

g/l

15.57

16783

162074

(3010813) Leukocytes [#/volume] in Blood

16994

164732

1.38

31.01

28.7

22.7

6.79

6.78

e9/l

0.14

16596

159409

(4034850) Laboratory test

762

4891

1.58

30.47

12.1

10.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

736

4686

1.59

30.46

1.4

284.86

266.64

ug/g

1.63

452

2765

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1981

15202

1.34

30.40

3.9

5.88

5.82

kpa

1.50

1912

14746

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

8062

72555

1.20

30.10

2.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

201

834

2.43

30.05

1.4

1.5

5.38

6.22

u/l

1.23

168

693

(4200892) Spirometry reversibility

1524

11276

1.38

29.52

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

5721

49937

1.21

29.50

2.4

2.5

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1403

10241

1.40

29.47

6.8

8.5

1.43

1.36

1.91

1393

10169

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

170

659

2.59

29.36

1.1

1.02

1.07

u/l

1.19

316

(3002385) Erythrocyte distribution width [Ratio]

13534

127862

1.22

29.15

22.0

18.3

15.19

15.18

0.06

13337

125484

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1397

10219

1.40

28.96

6.8

8.7

0.71

0.67

2.51

1389

10151

(3007853) Bacteria identified in Skin by Aerobe culture

2337

18475

1.30

28.93

1.8

—

(3024869) Neuronal Ab [Presence] in Serum

276

3.53

28.80

1.1

—

(3002032) Base excess in Venous blood by calculation

1966

15184

1.33

28.78

4.0

3.9

2.20

1.88

mmol/l

3.99

1711

12868

(3024354) Oxygen [Partial pressure] in Venous blood

1653

12453

1.36

28.56

3.4

3.2

4.54

4.50

kpa

0.37

1593

12018

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

583

3563

1.66

28.49

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

583

3563

1.66

28.49

1.4

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

423

2382

1.79

27.79

1.3

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

6.31

27.72

6.3

9.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

714

4634

1.56

27.21

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

991

6891

1.46

27.16

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

1850

14295

1.33

26.90

2.3

2.5

66.90

69.42

e9/l

2.51

1429

10833

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

15588

149821

1.25

26.66

5.4

5.1

2.63

2.70

mmol/l

16.16

14235

136785

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

120

408

2.95

26.64

1.7

2.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

177

735

2.42

26.48

1.4

1.5

—

(3012544) pH of Venous blood

2013

15772

1.31

26.47

3.9

7.39

7.38

0.63

108

(3013512) EKG study

5362

46939

1.20

26.01

4.5

4.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

917

6371

1.46

25.24

4.0

3.9

25.08

24.85

mmol/l

1.75

845

5824

(3000991) Gas panel - Venous blood

1758

13603

1.32

25.24

6.6

7.9

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

143

551

2.61

25.08

1.2

1.8

30.00

29.53

umol/l

0.21

133

532

(3005322) IgE [Units/volume] in Serum or Plasma

1158

8450

1.40

24.27

1.3

189.35

233.36

u/ml

0.66

1071

7738

(3013139) Helicobacter pylori Ag [Presence] in Stool

1316

9833

1.36

23.84

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1217

8981

1.38

23.83

1.3

1.2

98.41

142.98

iu/ml

4.22

455

3279

(3041096) Erythrocytes [Presence] in Urine by Automated

4561

39626

1.20

23.53

4.3

3.5

—

(3020961) Endomysium IgA Ab [Titer] in Serum

898

6324

1.44

23.00

1.2

1.1

456.64

203.26

titre

0.89

152

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

830

5765

1.46

22.87

1.1

1.65

4.46

u/ml

0.48

(3022313) Gas panel - Capillary blood

1022

7383

1.41

22.70

3.8

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

153

640

2.40

22.61

1.2

41.60

63.46

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1048

7618

1.40

22.45

3.2

2.8

1.22

1.23

0.01

1041

7579

(3013247) Albumin in CSF/Albumin in Serum or Plasma

220

3.46

22.08

1.2

1.0

6.16

7.72

mg/g

1.29

206

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

665

4467

1.51

21.67

1.5

1.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1447

11128

1.33

21.57

2.5

2.8

10.21

10.59

g/l

2.46

1308

10176

(3014271) Vancomycin [Susceptibility]

198

942

2.11

21.51

3.5

3.0

—

(3009508) Creatinine [Moles/volume] in Urine

5578

49625

1.18

21.48

3.2

7.31

mmol/l

0.02

4619

41322

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

167

743

2.26

21.44

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

922

6634

1.41

20.95

1.3

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

165

739

2.24

20.86

2.8

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

896

6434

1.41

20.60

2.0

2.3

3.56

3.71

g/l

2.99

791

5740

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

847

6030

1.42

20.44

2.0

2.3

9.80

10.23

g/l

2.26

734

5290

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

845

6016

1.42

20.39

2.0

2.3

2.85

2.97

g/l

3.13

738

5318

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

897

6454

1.41

20.39

2.0

2.3

7.18

7.47

g/l

6.19

789

5754

(3023323) Follitropin [Units/volume] in Serum or Plasma

711

4906

1.47

20.29

1.4

1.3

28.23

31.09

iu/l

1.42

609

4222

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

895

6447

1.41

20.21

2.0

2.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4353

38083

1.19

20.21

2.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

690

4740

1.47

20.14

2.1

2.3

0.02

0.03

g/l

0.69

624

4288

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

167

763

2.20

20.14

1.1

—

(3025941) Bacteria identified in Stool by Culture

1111

8299

1.36

20.11

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

661

4508

1.48

20.02

1.6

1.18

g/l

0.04

626

4260

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

15193

146604

1.20

19.48

4.8

4.6

4.51

4.60

mmol/l

23.44

13924

134446

(3023511) Choriogonadotropin [Units/volume] in Urine

282

1568

1.81

19.47

1.5

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1169

8856

1.34

19.29

2.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

641

4381

1.48

19.21

1.6

0.23

0.24

g/l

0.85

603

4126

(3017732) Neutrophils [#/volume] in Blood

1347

10421

1.32

19.20

3.3

3.0

5.19

5.11

e9/l

0.07

1006

8115

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

714

4984

1.45

19.19

2.1

2.2

38.75

37.32

g/l

9.29

602

4271

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

769

5444

1.43

19.16

2.1

2.5

0.53

1.01

g/l

4.75

653

4589

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

384

2344

1.65

18.98

2.0

1.8

186.16

194.84

pmol/l

0.87

365

2178

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

504

3285

1.55

18.93

1.9

1.7

41.79

43.30

nmol/l

0.81

488

3154

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2170

17847

1.24

18.86

2.4

2.7

6.53

9.07

umol/l

12.85

1820

15494

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

692

4818

1.45

18.86

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

15062

145337

1.19

18.75

4.7

4.5

1.44

1.47

mmol/l

11.22

13705

132495

(3042517) Benzodiazepines panel - Urine

4.83

18.66

2.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

238

1273

1.88

18.62

1.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1027

7677

1.36

18.50

3.7

4.2

24.61

24.09

mmol/l

5.90

1000

7491

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1801

14554

1.26

18.24

2.9

3.0

192.55

220.78

ng/l

2.37

1635

13320

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

198

1003

1.98

18.22

1.7

2.1

18.63

17.28

nmol/l

1.51

191

933

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

749

5335

1.42

18.05

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

14586

140469

1.18

18.02

4.2

4.1

1.29

mmol/l

0.61

13136

126911

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

632

4364

1.46

18.00

2.2

2.4

0.00

g/l

-0.00

574

3987

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

856

6249

1.39

17.88

1.7

1.9

38.80

38.96

u/l

0.09

753

5433

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

640

4436

1.46

17.87

2.2

2.3

0.00

g/l

0.50

577

4002

(3026493) Urate [Moles/volume] in Serum or Plasma

4668

41508

1.17

17.26

2.6

2.7

3623.53

5057.69

umol/l

1.89

3963

35813

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

100

391

2.57

17.18

1.2

1.1

—

(3042936) Bacteria identified in Isolate by Culture

2642

22385

1.21

17.09

2.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1280

10001

1.30

16.93

2.5

2.1

12.47

11.98

nmol/l

1.25

1124

8790

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

974

7346

1.34

16.55

4.5

4.1

50.15

47.49

2.89

960

7259

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

532

3617

1.48

16.42

1.1

4.46

8.22

u/ml

1.45

394

(46235355) HIV 1 and 2 tests - Meaningful Use set

2445

20640

1.21

16.38

1.8

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

780

5700

1.38

16.21

1.9

1.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

508

3432

1.49

16.19

1.3

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

628

4432

1.43

15.96

1.6

1.7

3.18

3.96

mg/l

1.74

509

3239

(3004119) Hemoglobin [Mass/volume] in Venous blood

1256

9865

1.29

15.96

3.5

3.4

128.77

127.87

g/l

0.78

1226

9620

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1329

10535

1.28

15.71

2.3

1.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

5703

51784

1.15

15.46

5.1

5.3

3.23

3.65

ug/l

0.38

5060

46081

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1662

13561

1.25

15.39

3.5

3.9

1.23

mmol/l

0.04

1420

11779

(21494755) Public health laboratory ask at order entry panel

764

10270

0.73

15.35

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

545

3776

1.46

15.31

2.1

2.3

129.44

127.91

g/l

0.73

409

2696

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

840

6271

1.36

15.28

1.9

1.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

508

3490

1.47

14.92

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2556

21863

1.20

14.77

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

901

6837

1.33

14.71

2.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

530

3684

1.45

14.65

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1201

9485

1.28

14.61

2.1

1.9

—

(3052851) Hemolysis interference index of Serum or Plasma

680

4944

1.39

14.60

3.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1031

7988

1.31

14.52

4.0

3.4

25.44

25.20

mmol/l

1.55

990

7753

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

434

2906

1.51

14.49

1.2

51.53

45.54

u/ml

0.29

300

(3047181) Lactate [Moles/volume] in Blood

703

5150

1.38

14.42

5.1

5.9

1.22

1.33

mmol/l

2.43

631

4549

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

120

552

2.18

14.38

1.1

2353.84

575.30

ng/l

0.46

131

(3008295) Osmolality of Serum or Plasma

262

1561

1.69

14.34

1.5

1.4

282.87

278.00

mosm/kgh2o

2.36

192

1179

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

4593

41263

1.15

14.27

4.5

22.19

22.15

0.05

2241

21187

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

109

488

2.24

13.97

1.1

—

(3000492) Spirometry study

1661

13696

1.23

13.93

1.5

—

(3045414) Leukocytes [Presence] in Urine

905

6929

1.32

13.89

2.0

1.9

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

335

2148

1.57

13.66

1.3

0.55

0.20

nmol/l

3.17

146

(3020191) Ethanol [Moles/volume] in Serum or Plasma

191

1055

1.82

13.64

1.5

1.4

1.14

1.32

promille

0.96

149

810

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

568

4053

1.41

13.63

1.3

1.2

41.53

41.99

u/ml

0.01

244

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

618

4477

1.39

13.58

1.9

1.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

170

915

1.87

13.21

1.3

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

871

6684

1.32

13.16

2.0

1.9

1.97

2.18

ug/l

0.25

739

5874

(3009214) Lutropin [Units/volume] in Serum or Plasma

461

3190

1.46

13.09

1.4

10.14

10.95

u/l

0.66

370

2581

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

111

517

2.15

12.95

2.6

2.9

25.13

28.34

umol/l

1.73

386

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

372

2.37

12.92

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

331

2145

1.55

12.91

1.3

0.61

1.95

nmol/l

1.13

317

2053

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

325

2100

1.56

12.84

2.0

2.1

21.00

26.57

mg/l

1.16

565

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

425

2.27

12.69

1.1

1.2

24.50

22.39

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

376

2.35

12.63

1.1

—

(3003338) MCHC [Mass/volume]

12835

123441

1.13

12.52

25.8

20.1

331.64

331.84

g/l

1.62

12724

122410

(3022145) Colonoscopy Study observation

2028

17236

1.20

12.46

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

584

4256

1.38

12.42

2.8

3.1

25.37

24.76

mmol/l

3.33

576

4163

(3035637) Corticotropin [Mass/volume] in Plasma

286

1814

1.59

12.27

1.4

1.5

—

(3003181) Sodium [Moles/volume] in Urine

425

2935

1.46

12.23

1.3

1.4

64.20

63.24

mmol/l

0.19

338

2331

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

376

2.32

12.18

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

305

1969

1.56

12.13

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

165

907

1.83

12.03

1.3

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2219

19086

1.18

11.88

3.1

4.1

233.24

247.47

u/l

5.46

2044

17975

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1767

14902

1.21

11.78

2.0

2.2

0.21

g/l

4.16

1635

13814

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

402

2.24

11.68

1.3

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

347

2.34

11.59

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

373

2.28

11.51

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1736

14649

1.20

11.50

5.7

7.0

9.61

10.44

mmol/l

5.44

1623

13861

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

519

3760

1.39

11.47

1.3

5.90

6.05

u/ml

0.04

623

(3028626) Oxygen [Partial pressure] in Capillary blood

518

3769

1.39

11.16

3.1

8.20

8.05

kpa

1.37

510

3677

(3012516) Albumin [Mass/volume] in Urine

5194

47653

1.12

11.11

3.2

3.3

548.85

407.76

mg/l

1.05

3283

30267

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.70

11.08

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

106

517

2.06

11.04

1.3

1.2

—

(3021901) Oxygen saturation in Capillary blood

437

3095

1.42

11.02

2.7

2.9

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

445

2.14

11.00

1.4

1.3

79.42

181.84

nmol/24h

1.56

445

(3008898) HLA-B27 [Presence]

550

4054

1.37

10.95

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

509

3715

1.38

10.78

1.3

11.86

4.47

u/ml

0.63

404

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

979

7844

1.26

10.62

1.6

1.54

1.56

g/l

0.29

813

6697

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1923

16499

1.18

10.55

4.0

3.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

505

3697

1.38

10.51

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

449

3226

1.40

10.46

2.4

2.1

4494.04

4991.55

u/l

0.14

149

1231

(3009445) Proteinase 3 Ab [Units/volume] in Serum

871

6894

1.28

10.46

1.4

1.5

27.21

14.15

u/ml

0.65

176

(40761536) Microorganisms panel - Urine sediment

1547

13040

1.20

10.35

5.1

4.1

—

(3028717) Thiamine [Mass/volume] in Blood

147

3.00

10.33

1.2

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

864

6847

1.27

10.27

4.6

5.0

1.64

0.01

807

6422

(40757494) Bilirubin.total [Moles/volume] in Blood

154

873

1.77

10.22

2.4

2.1

14.25

28.57

umol/l

1.50

(3017509) Phencyclidine [Presence] in Urine

3.52

10.01

2.0

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

119

627

1.90

10.00

2.9

1.8

138.69

116.49

umol/l

0.35

334

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1067

8694

1.24

9.99

7.0

8.7

24.62

24.30

mmol/l

2.43

1016

8364

(3049717) Cytology report of Urine Cyto stain

836

6630

1.27

9.89

2.4

2.8

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

849

6750

1.27

9.84

4.7

5.1

0.90

0.89

0.53

794

6330

(3040151) Glucose [Moles/volume] in Capillary blood

283

1888

1.51

9.78

13.9

10.3

7.35

7.46

mmol/l

0.21

235

1562

(3039000) Anion gap in Blood

492

3645

1.36

9.54

5.8

6.8

10.84

11.24

mmol/l

1.56

443

3277

(43055514) Macroprolactin [Presence] in Serum or Plasma

240

2.46

9.54

1.3

1.5

—

(3018572) Chloride [Moles/volume] in Blood

492

3646

1.36

9.53

5.8

6.8

105.14

105.02

mmol/l

0.21

443

3278

(3022621) pH of Urine by Test strip

1248

10392

1.22

9.49

3.7

3.1

—

(40768804) Tissue Pathology biopsy report

6671

62518

1.10

9.22

2.1

2.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

148

2.84

9.02

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

307

2120

1.46

8.97

1.9

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2224

19553

1.16

8.92

4.9

4.7

33.32

32.79

1.41

1533

13143

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1171

9757

1.21

8.85

5.7

6.8

25.22

24.77

mmol/l

4.02

1158

9665

(3011985) Renin [Units/volume] in Plasma

294

2020

1.46

8.83

1.4

57.60

60.41

mu/l

0.11

259

1784

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

278

1893

1.48

8.74

1.3

292.69

359.21

pmol/l

0.59

232

1617

(3010421) pH of Blood

566

4340

1.31

8.72

3.9

4.0

7.42

0.55

503

3963

(3020682) Albumin/Creatinine [Ratio] in Urine

5403

50209

1.11

8.70

3.8

7.94

9.45

mg/mmol

1.56

3359

31450

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

838

10327

0.80

8.64

1.7

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

498

1.93

8.52

1.3

1.4

13.98

16.06

pmol/l

3.29

405

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

142

2.82

8.50

1.1

1.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

288

1987

1.46

8.48

1.1

5.28

11.38

au/ml

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4341

39926

1.11

8.46

1.6

1.36

1.35

mmol/l

0.32

3637

33152

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1064

8831

1.22

8.38

7.7

9.3

—

(1616796) Gas panel - Central venous blood

490

3704

1.33

8.37

3.6

3.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1054

8741

1.22

8.37

1.8

1.9

1.47

1.36

g/l

0.51

947

7907

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

347

2487

1.40

8.30

1.2

1.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

137

801

1.72

8.26

1.3

1.2

288.00

342.86

u/l

0.25

125

737

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

423

3143

1.35

8.12

1.2

14.76

11.91

u/ml

0.12

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

296

2072

1.44

8.10

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

296

2073

1.43

8.08

1.1

33480.22

685.11

iu/ml

0.48

452

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

4.12

7.98

1.0

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

677

5386

1.27

7.88

1.5

1.6

134.25

276.97

titre

2.41

246

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

6.56

7.86

1.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1469

12635

1.18

7.81

2.7

65.67

63.01

ml/min/173m2

1.86

601

5191

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

179

2.52

7.70

2.3

2.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

463

3518

1.32

7.67

1.7

1.8

49.21

4.54

iu/l

0.80

138

1220

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

3.10

7.53

1.0

1.5

42.78

33.61

0.45

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

286

2021

1.42

7.47

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

416

3127

1.34

7.44

1.2

2.34

4.73

u/ml

1.02

239

(3024522) Salmonella sp identified in Specimen by Organism specific culture

287

2032

1.42

7.42

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

336

2.06

7.37

1.1

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

6.80

7.27

1.5

201.90

241.94

nmol/l

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

170

1087

1.57

7.26

1.4

—

(1761868) Lipid panel - Serum or Plasma

4475

48145

0.91

7.24

3.0

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

6.21

7.22

1.4

1.6

161.08

250.43

nmol/l

1.04

(3037121) Protein [Mass/volume] in Urine

688

5556

1.25

7.08

2.8

3.0

0.26

0.31

g/l

1.22

249

2334

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1019

8571

1.20

7.02

3.1

2.8

0.30

e6/l

0.00

986

8380

(4035726) Immunohistochemistry procedure

1228

14302

0.85

6.99

1.3

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

281

2007

1.41

6.94

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

281

2009

1.40

6.90

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

281

2012

1.40

6.85

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

229

1580

1.45

6.84

2.7

2.9

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

160

2.50

6.81

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

176

1152

1.53

6.81

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

259

1832

1.42

6.77

1.3

1.2

30.84

57.95

u/ml

1.44

136

(3019832) Treponema pallidum Ab [Presence] in Serum

1049

8890

1.19

6.67

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

170

1111

1.54

6.63

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

193

2.33

6.60

2.2

2.1

—

(3045424) Erythrocytes [Presence] in Urine

346

2580

1.35

6.58

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

123

747

1.65

6.54

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

129

795

1.63

6.48

1.1

—

(3044927) Protein electrophoresis panel - Urine

245

1733

1.42

6.43

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

110

653

1.69

6.39

1.2

155.49

158.76

mmol/24h

0.16

110

653

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

241

1702

1.42

6.39

1.1

2.97

3.57

u/ml

0.29

722

(3010838) Calcium [Moles/time] in 24 hour Urine

367

2775

1.33

6.37

1.9

1.8

4.85

4.95

mmol/24h

0.14

322

2416

(3024928) Oxygen saturation in Venous blood

433

3351

1.30

6.36

2.7

3.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

107

632

1.70

6.33

2.5

2.3

53.61

53.17

umol/l

0.05

531

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

3.03

6.32

1.0

1.5

6.06

14.32

2.13

(3024980) IgG subclass 4 [Mass/volume] in Serum

317

2353

1.35

6.24

1.6

0.64

0.81

g/l

2.32

239

1767

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

701

5756

1.23

6.22

2.6

2.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

192

1306

1.48

6.22

1.6

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

455

3557

1.29

6.19

2.9

2.6

16.52

16.06

1.70

279

1835

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

236

1671

1.42

6.18

1.3

1.4

31.97

29.93

u/l

0.37

190

1363

(3027315) Oxygen [Partial pressure] in Blood

483

3811

1.27

6.11

4.0

4.1

8.56

8.51

kpa

0.24

470

3723

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1749

15522

1.14

6.10

1.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

123

762

1.62

6.08

1.5

1.3

—

(3012501) Base excess in Blood by calculation

480

3788

1.27

6.07

3.9

4.1

2.60

2.59

mmol/l

0.03

349

2588

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

3.01

6.05

1.2

1.4

—

13114.83

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.01

6.05

1.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

503

3994

1.27

6.05

1.1

—

(3013290) Carbon dioxide [Partial pressure] in Blood

480

3790

1.27

6.05

4.0

4.1

5.11

4.99

kpa

3.45

468

3702

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

127

799

1.59

5.90

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

127

799

1.59

5.90

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

223

1577

1.42

5.90

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.86

5.76

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

319

2408

1.33

5.66

1.6

—

(4062490) Immunoglobulin typing, IgG

210

1482

1.42

5.64

1.5

1.4

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.76

5.61

1.0

1.2

65.74

44.79

mg/l

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

148

977

1.52

5.59

1.3

2.41

1.64

u/ml

0.27

559

(3036489) Thrombin time

668

5532

1.22

5.50

1.8

2.0

21.43

21.68

0.36

595

4865

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

103

629

1.64

5.44

1.7

1.6

4.93

3.98

nmol/l

0.19

521

(3047007) Chlamydophila sp Ab [Presence] in Serum

250

1831

1.37

5.42

1.3

1.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

211

2.14

5.41

1.1

1.3

41.50

53.51

0.77

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

428

1.78

5.38

1.2

106.35

113.08

1.52

374

(3017181) Myelocytes/100 leukocytes in Blood

1500

13292

1.14

5.37

3.6

4.0

0.91

0.96

0.30

466

4706

(4146454) Self-monitoring of blood glucose

248

1820

1.37

5.32

2.7

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

209

1491

1.41

5.31

1.5

1.3

6.40

6.89

g/l

0.96

144

1031

(3024139) IgG subclass 3 [Mass/volume] in Serum

209

1491

1.41

5.31

1.5

1.3

0.38

0.43

g/l

1.51

145

1033

(3028192) IgG subclass 2 [Mass/volume] in Serum

209

1492

1.41

5.29

1.5

1.3

2.82

2.93

g/l

0.41

143

1037

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

2.62

5.29

1.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

1427

12620

1.14

5.26

3.7

4.0

0.15

0.10

1.00

400

4053

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

6.67

5.24

1.8

1.9

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

2.98

5.24

1.0

1.4

3.38

0.96

0.56

(3023419) Bacteria identified in Sputum by Culture

328

2517

1.31

5.21

2.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

254

1887

1.35

5.06

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

588

1.64

5.04

1.8

2.1

23.20

317.07

ug/l

1.61

556

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

315

1.88

4.99

1.1

1.2

0.60

58.05

mg/l

1.44

236

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

461

1.72

4.98

1.2

0.32

0.31

g/l

0.27

368

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

601

1.62

4.88

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.34

4.87

1.5

1.4

439.94

449.41

nmol/l

0.02

(3017143) Hepatitis C virus Ab [Presence] in Serum

1648

14783

1.13

4.87

1.6

—

(3025159) Blasts/100 leukocytes in Blood

1344

11905

1.14

4.86

3.7

4.0

0.35

0.37

0.04

320

3404

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

280

2125

1.32

4.85

1.1

2.05

1.76

u/ml

0.18

142

1038

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

117

759

1.54

4.85

1.1

—

(3016038) Potassium [Moles/volume] in Urine

156

1075

1.45

4.84

1.2

32.79

34.75

mmol/l

0.58

134

894

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

201

2.09

4.83

1.1

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

645

5398

1.20

4.81

2.3

3.3

13.11

4.41

ratio

0.36

409

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.63

4.80

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

660

5545

1.20

4.73

2.3

3.3

34.23

46.58

mg/l

2.53

536

4452

(3000475) Leukocytes [#/volume] in Synovial fluid

481

3920

1.23

4.69

1.7

1.6

12490.44

14799.24

e6/l

0.68

364

2817

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

491

4012

1.23

4.68

1.8

2.0

10.69

11.60

mg/l

1.76

455

3710

(3006270) Folate [Moles/volume] in Blood

194

1401

1.39

4.65

1.2

337.54

346.37

nmol/l

0.26

157

1141

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

547

1.63

4.65

1.2

1.3

4.39

3.95

umol/l

0.57

506

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

367

2906

1.27

4.62

1.8

1.7

0.81

0.83

nmol/l

0.12

294

2421

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

115

2.44

4.61

1.0

1.1

16.14

11.17

u/l

0.34

115

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

122

809

1.51

4.60

1.1

9.84

9.67

iu/ml

0.01

190

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

154

1070

1.44

4.59

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

659

5555

1.19

4.56

2.3

3.3

54.21

68.59

mg/l

0.57

536

4453

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

154

1072

1.44

4.55

1.1

—

(3019977) pH of Arterial blood

139

949

1.47

4.55

2.5

2.6

7.43

7.42

0.98

343

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

153

1065

1.44

4.53

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

537

4445

1.21

4.52

1.4

21.60

14.44

iu/ml

0.40

100

(3026389) Candida sp identified in Specimen by Organism specific culture

295

2280

1.30

4.51

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

111

727

1.53

4.44

1.4

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

153

1070

1.43

4.43

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

105

681

1.54

4.40

1.2

1.5

25.30

23.95

umol/l

0.17

646

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

568

6776

0.83

4.38

1.5

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

152

1065

1.43

4.36

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

392

3158

1.25

4.29

1.1

1.2

180.00

149.28

titre

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

251

1912

1.32

4.29

1.1

5.07

4.78

u/ml

0.10

114

941

(3019420) Tryptase [Mass/volume] in Serum or Plasma

107

702

1.53

4.27

1.2

1.5

6.23

8.72

ug/l

2.08

637

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

165

2.12

4.23

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

198

1460

1.36

4.22

1.1

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1351

12084

1.13

4.22

3.4

3.9

0.70

0.71

0.01

392

4050

(40759836) Histone Ab [Presence] in Serum by Immunoblot

151

1064

1.42

4.21

1.1

—

(3035060) Mercury [Moles/volume] in Blood

5.88

4.12

1.6

1.9

10.94

12.57

nmol/l

—

(4281824) Cell count and differential, peritoneal fluid

122

1762

0.69

4.07

1.2

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3159

29536

1.08

4.03

3.2

0.73

0.79

ug/l

2.52

2235

20573

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.50

4.03

1.3

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

223

1689

1.32

4.00

1.1

1.89

1.25

u/ml

0.74

110

818

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

210

1.95

3.99

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

554

1.57

3.99

1.4

1.8

1.81

1.96

umol/l

1.33

518

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

131

2.22

3.91

1.3

16.98

17.67

pmol/l

0.04

116

(3007463) Buprenorphine [Presence] in Urine

4.06

3.89

3.8

7.3

—

(3051593) INR in Capillary blood by Coagulation assay

123

849

1.45

3.87

7.7

10.9

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

323

2580

1.26

3.86

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

396

1.67

3.85

1.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

216

1643

1.32

3.78

4.1

3.6

—

(3023420) DNA double strand Ab [Units/volume] in Serum

200

1509

1.33

3.72

1.5

27.50

28.57

iu/ml

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

508

4270

1.20

3.71

1.9

1.8

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

325

1.73

3.70

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

211

1612

1.31

3.60

1.4

0.30

0.35

nmol/l

0.86

171

1199

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

443

3691

1.21

3.57

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

643

1.50

3.55

1.3

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

514

4344

1.19

3.55

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

466

3904

1.20

3.55

1.5

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

166

1228

1.35

3.54

1.6

2.0

7.78

8.43

umol/l

0.17

114

899

(3051611) Lipemic interference index of Serum or Plasma

228

1770

1.29

3.47

3.4

3.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

277

3453

0.80

3.40

1.4

1.5

—

(3030313) Adrenal Ab [Titer] in Serum

101

2.28

3.35

1.0

—

(3028271) Lactate [Moles/volume] in Capillary blood

328

2672

1.23

3.34

2.2

1.9

1.69

1.71

mmol/l

0.14

319

2614

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

390

1.62

3.31

1.7

1.5

0.43

0.37

ug/l

0.49

241

(3008401) Mugwort IgE Ab [Units/volume] in Serum

234

1836

1.28

3.30

1.1

0.81

1.09

u/ml

0.42

752

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.41

3.29

1.2

1.0

32.36

47.57

u/l

1.33

(44813793) Dust mix specific IgE antibody measurement

132

956

1.38

3.24

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

490

4167

1.18

3.19

2.7

2.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

189

1450

1.31

3.18

1.1

4.65

3.29

u/ml

0.43

659

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

157

1.98

3.18

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

643

1.46

3.17

1.1

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.96

3.13

1.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

271

2182

1.25

3.10

5.6

6.4

12.00

11.96

mg/l

0.07

241

1985

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

178

1360

1.31

3.10

2.2

2.1

2.18

2.10

u/field

0.06

540

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

125

1705

0.73

3.07

1.4

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

119

858

1.39

3.03

1.4

158.77

172.68

pmol/l

0.44

119

858

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.89

3.02

1.2

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

203

1.82

3.01

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

176

1350

1.31

2.99

1.1

4.83

3.47

u/ml

0.36

522

(3013336) Amino acids [Identifier] in Serum or Plasma

4.29

2.99

1.1

3.5

—

(3029075) Extractable nuclear Ab panel - Serum

409

1.57

2.99

1.0

1.1

—

(3020491) Glucose [Moles/volume] in Blood

150

1125

1.34

2.99

2.0

1.9

7.05

6.98

mmol/l

0.09

107

778

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

211

1.80

2.98

1.1

—

(3019230) Fractional oxyhemoglobin in Venous blood

326

2691

1.22

2.97

2.8

2.9

64.03

63.51

0.16

326

2678

(3000060) B lymphocytes [#/volume] in Blood

355

1.61

2.96

2.8

2.0

200.53

686.54

e6/l

1.22

188

(3038177) Helicobacter pylori Ab [Presence] in Serum

278

2258

1.23

2.96

1.3

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

205

2593

0.79

2.92

3.0

3.6

27.60

38.13

u/ml

1.48

200

2511

(3007566) Smooth muscle Ab [Titer] in Serum

465

3974

1.17

2.89

1.2

144.86

136.80

titre

0.07

344

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

130

961

1.36

2.86

2.7

2.4

480.85

514.57

e6/l

0.46

112

805

(3052592) Norovirus Ag [Presence] in Stool

343

1.61

2.86

1.2

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.25

2.86

1.1

—

(3003577) Lead [Moles/volume] in Blood

2.29

2.83

1.1

1.3

0.08

0.20

umol/l

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

310

2560

1.21

2.83

1.2

1.3

36.23

37.21

u/l

0.04

261

2197

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

207

1642

1.26

2.74

1.4

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

131

1.99

2.74

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

198

1563

1.27

2.73

1.3

1.4

135366.83

138761.86

e6/l

0.02

133

1071

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

140

1841

0.76

2.73

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

334

2790

1.20

2.72

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

140

1840

0.76

2.72

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

203

1.77

2.71

1.3

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

212

1689

1.26

2.71

1.3

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

212

1689

1.26

2.71

1.3

1.5

—

(3005033) Fetal Nuchal fold Thickness US

110

1496

0.73

2.70

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

141

1849

0.76

2.70

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

288

2375

1.22

2.69

1.1

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

141

1847

0.76

2.68

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

320

2667

1.20

2.68

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

105

2.10

2.67

1.3

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

326

1.60

2.67

1.2

1.3

62.57

78.98

mu/l

0.30

238

(3047352) Trisomy 18 risk [Likelihood] in Fetus

111

1502

0.74

2.65

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

275

2261

1.22

2.65

1.1

—

(3017569) Oxygen content in Arterial blood

108

787

1.37

2.63

2.3

2.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

101

729

1.39

2.61

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

452

3890

1.17

2.61

1.4

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

445

3826

1.17

2.60

1.5

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1185

0.71

2.60

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

293

2430

1.21

2.59

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

484

4190

1.16

2.59

2.3

3.4

—

(3051651) Icteric interference index of Serum or Plasma

131

987

1.33

2.58

3.3

3.8

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

124

928

1.34

2.56

2.7

2.5

0.24

e9/l

0.00

113

806

(40768800) Prostate Pathology biopsy report

282

3388

0.83

2.52

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

232

1887

1.23

2.50

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

1164

0.71

2.50

1.0

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1656

17800

0.92

2.49

3.1

4.0

10.92

24.29

ug/l

3.08

1312

14614

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

372

1.53

2.49

1.4

1.2

—

(3037756) Immunofixation for Serum or Plasma

429

3695

1.16

2.47

1.4

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

286

1.61

2.47

1.1

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

318

1.57

2.44

1.4

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

267

2212

1.21

2.42

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

335

1.55

2.41

1.2

1.1

0.68

0.66

umol/24h

0.11

156

(3034770) Mitochondria Ab [Titer] in Serum

457

3964

1.16

2.41

1.1

1.2

606.00

890.93

titre

—

129

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

236

1934

1.22

2.39

1.1

1.48

1.53

g/l

1.25

204

1751

(3035947) Staphylolysin Ab [Units/volume] in Serum

103

759

1.36

2.38

1.1

2.80

3.84

iu/ml

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

118

1552

0.76

2.36

1.4

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2205

20765

1.07

2.34

1.5

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

157

1984

0.79

2.30

1.4

1.5

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

519

1.43

2.29

1.6

1.5

599437.67

1521426.92

iu/ml

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

344

2932

1.18

2.29

2.5

3.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

511

1.43

2.29

2.3

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

511

1.43

2.29

2.3

2.6

—

(40768806) Pleura Pathology biopsy report

151

1914

0.79

2.27

1.6

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

413

1.48

2.27

1.1

1.2

84.66

87.00

0.22

199

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

163

1.78

2.26

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

156

1.80

2.24

1.1

1.62

1.68

umol/24h

0.15

156

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

142

1.83

2.22

1.6

2.0

—

(3003694) ABO and Rh group [Type] in Blood

4124

39628

1.05

2.21

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

298

2518

1.19

2.21

1.4

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

298

2518

1.19

2.21

1.4

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

294

2483

1.19

2.20

1.4

115.53

117.48

u/ml

0.11

544

(3028679) Herpes simplex virus Ab [Presence] in Serum

642

1.37

2.19

1.1

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

719

1.35

2.19

3.2

3.1

19.33

27.99

mu/l

1.83

672

(3028433) Virus identified in Specimen by Culture

516

1.42

2.19

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

234

1.63

2.15

1.2

1.3

153.31

494.35

ng/l

0.47

155

(3019897) Erythrocyte distribution width [Ratio] by Automated count

114

1482

0.77

2.13

3.9

3.0

13.17

13.22

0.18

114

1460

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

150

1187

1.27

2.12

1.1

1.0

0.08

0.37

u/ml

1.82

332

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

147

1162

1.27

2.10

1.2

1.3

9.03

8.81

mmol/l

0.22

138

1108

(3044941) Cell count panel - Synovial fluid

295

2506

1.18

2.08

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

117

901

1.30

2.05

1.9

1.64

2.88

u/field

1.66

627

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

423

3699

1.15

2.05

1.5

1.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

625

1.36

2.04

3.2

2.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

164

1319

1.25

2.03

4.2

4.9

140.62

113.59

u/ml

0.19

401

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

215

1.63

2.02

2.9

2.6

0.66

0.58

u/field

0.16

215

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

687

1.34

2.01

1.1

1.2

—

(40768793) Breast Pathology biopsy report

286

3353

0.85

2.00

1.3

—

(3044009) aPTT.lupus sensitive (LA screen)

111

1.89

2.00

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

368

1.47

1.99

1.1

1.2

540.31

300.60

pmol/l

0.33

264

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

426

1.43

1.98

1.1

89.59

87.10

0.26

201

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

377

1.46

1.97

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

377

1.46

1.97

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

377

1.46

1.97

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

377

1.46

1.97

1.0

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.08

1.96

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.02

1.95

1.1

1.0

0.03

0.54

u/ml

0.89

(3006567) Chloride [Moles/time] in 24 hour Urine

2.96

1.93

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.75

1.93

1.0

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1888

17816

1.07

1.92

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

186

1530

1.22

1.89

1.4

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

105

810

1.30

1.85

2.0

2.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

169

1380

1.23

1.85

1.4

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

169

1380

1.23

1.85

1.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

169

1380

1.23

1.85

1.4

1.6

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

628

1.34

1.85

1.1

2.63

6.33

u/ml

2.15

100

(3004451) EKG impression Narrative

107

828

1.29

1.85

1.3

—

(3016330) Potassium [Moles/time] in 24 hour Urine

205

1.61

1.85

1.4

1.2

—

86.59

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

449

3975

1.13

1.84

2.1

2.3

105.70

109.50

ug/min

0.07

255

2309

(3017817) Protein [Mass] in Urine collected for unspecified duration

179

1472

1.22

1.84

2.2

2.3

—

0.36

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

3.53

1.83

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

405

0.59

1.83

7.0

7.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

320

2772

1.16

1.81

1.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

137

1098

1.25

1.79

1.3

746.47

405.10

titre

0.39

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

311

1.48

1.79

1.0

10.93

11.77

u/ml

0.06

169

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

176

1.65

1.78

1.1

1.0

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

239

1.55

1.77

1.5

1.7

27.85

51.40

pmol/l

1.96

196

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

133

1065

1.25

1.76

1.3

90.00

61.51

titre

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

625

1.33

1.76

1.2

1.1

7.07

16.65

u/ml

0.55

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

487

4350

1.12

1.75

2.1

2.5

3.55

3.62

g/l

0.50

458

4143

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

1.90

1.74

1.1

1.0

0.01

3.98

u/ml

0.54

(1175426) CD3 cells/100 lymphocytes in Blood

138

1111

1.24

1.74

2.4

2.0

73.92

71.84

1.08

133

1057

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

123

978

1.26

1.73

1.5

1.7

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

578

0.67

1.70

2.1

2.0

403.95

3437.85

e6/l

1.19

393

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

282

0.53

1.70

3.5

2.7

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

103

804

1.28

1.69

1.6

1.4

1.17

1.20

nmol/l

0.11

622

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.95

1.69

1.2

1.1

—

2.04

—

(3050129) First trimester maternal screen panel - Serum or Plasma

194

2309

0.84

1.68

1.3

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

260

2232

1.17

1.68

1.5

—

(3024263) Appearance of Synovial fluid

106

832

1.28

1.67

1.5

1.3

—

(40768443) Skin Pathology biopsy report

780

7159

1.09

1.67

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

344

0.58

1.67

7.0

7.6

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.86

1.65

1.6

1.5

0.62

0.74

umol/l

0.44

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

119

1.77

1.65

1.2

1.3

1.40

0.98

ml/s/173m2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

359

3161

1.14

1.64

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

384

1.41

1.64

1.7

1.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

259

2230

1.16

1.62

1.5

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

100

1268

0.79

1.61

1.3

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

130

1051

1.24

1.61

1.2

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

101

793

1.28

1.60

1.7

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

101

793

1.28

1.60

1.7

1.5

—

(3033799) Differential panel - Peritoneal fluid

510

0.67

1.59

2.6

1.8

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.50

1.59

1.3

1.1

1.50

2.63

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

182

1.59

1.1

100.44

78.01

ug/l

1.46

143

(40761539) Cells [Type] in Urine sediment by Light microscopy

412

1.38

1.59

1.3

1.2

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.69

1.58

1.1

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

155

1868

0.83

1.57

1.3

1.2

7.39

7.52

mmol/l

0.23

135

1615

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

543

5986

0.90

1.55

2.6

3.4

849.56

1800.54

u/ml

0.83

452

5126

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

207

1761

1.18

1.53

1.2

58.92

61.80

u/l

0.43

184

1569

(3035320) C reactive protein [Mass/volume] in Body fluid

137

1122

1.22

1.52

3.6

2.5

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.43

1.47

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

548

1.32

1.47

1.0

0.51

1.88

u/ml

0.62

147

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

788

0.75

1.44

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.88

1.44

8.1

4.6

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

327

1.41

1.44

1.0

1.1

5.07

4.14

u/ml

0.08

168

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

236

1.48

1.43

2.1

2.7

99.80

69.01

mg/l

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.73

1.43

2.7

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

559

1.31

1.43

1.1

1755.89

1537.34

miu/ml

0.85

559

(3020874) Milk IgE Ab [Units/volume] in Serum

647

1.28

1.43

1.1

8.91

1.58

u/ml

0.40

218

(3018851) Theophylline [Moles/volume] in Serum or Plasma

164

1.59

1.42

2.0

1.7

36.12

47.23

umol/l

1.74

164

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

282

2473

1.14

1.42

1.2

1.3

308.78

282.66

u/ml

0.53

169

1559

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

127

1042

1.22

1.41

2.6

2.0

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.82

1.41

1.6

1.5

0.85

1.65

mg/l

0.71

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

238

2064

1.16

1.40

1.2

2.05

4.02

u/ml

2.87

690

(3001019) Free T4 and TSH panel - Serum or Plasma

628

5763

1.09

1.40

1.9

1.7

—

(3011412) CD3 cells [#/volume] in Blood

167

1408

1.19

1.40

2.6

2.3

1.21

1.15

e9/l

0.47

153

1268

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

2.41

1.39

1.0

1.1

—

32.38

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

232

2010

1.16

1.39

1.2

3.63

3.96

u/ml

0.24

889

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1023

9578

1.07

1.38

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

246

2142

1.15

1.38

1.4

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

288

1.42

1.38

1.1

1.2

71.42

71.69

0.02

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

153

1282

1.20

1.37

1.5

1.6

32.31

24.51

u/ml

0.95

265

(3018291) Platelet Ab [Presence] in Serum

2.61

1.36

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

479

0.69

1.35

1.3

1.5

—

(3044007) Cell count panel - Peritoneal fluid

455

0.68

1.35

2.9

1.8

—

(3000285) Sodium [Moles/volume] in Blood

215

1.49

1.35

1.1

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

165

0.48

1.34

1.6

2.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

769

1.25

1.34

1.1

1.07

1.06

ratio

0.36

255

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

183

1.53

1.33

1.5

1.4

0.26

0.23

nmol/l

0.17

129

(3036071) Salmonella sp Ab [Titer] in Serum

409

1.35

1.33

1.1

—

(3000330) Specific gravity of Urine by Test strip

893

8334

1.08

1.33

4.2

3.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

199

1712

1.16

1.32

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.81

1.31

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

270

0.59

1.30

5.1

6.8

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

507

1.30

1.29

1.3

1.4

58.40

56.10

0.18

431

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

326

1.38

1.29

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

127

1524

0.83

1.28

1.6

1.7

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

109

891

1.22

1.28

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

103

839

1.23

1.26

1.1

18.55

26.02

u/l

1.66

748

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

103

840

1.23

1.24

1.1

71.90

85.65

u/l

2.05

754

(3045142) Bone marrow Pathology biopsy report

154

1811

0.85

1.24

1.2

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

449

1.32

1.24

1.2

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

118

0.42

1.24

1.0

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

411

0.68

1.24

1.3

1.4

11.46

13.94

g/l

0.61

317

(3003434) Protein [Mass/volume] in Pleural fluid

214

2453

0.87

1.24

1.4

1.5

33.19

32.23

g/l

0.54

193

2192

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

108

886

1.22

1.24

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

178

1528

1.17

1.24

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

451

4105

1.10

1.23

2.1

2.5

185.52

196.91

1.91

430

3886

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

329

1.37

1.23

1.8

1.5

105.89

117.84

ng/l

0.20

329

(40768441) Liver Pathology biopsy report

1101

0.81

1.23

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

187

1.50

1.23

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

770

1.23

1.22

1.3

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

309

2758

1.12

1.22

1.3

1.4

23.58

17.90

u/ml

—

(3009871) Measles virus Ab [Titer] in Serum

433

0.69

1.22

1.7

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

1.72

1.20

1.1

1.0

0.01

0.58

u/ml

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.80

1.20

1.6

1.3

1.25

1.15

u/field

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

408

1.32

1.20

3.9

5.6

69.03

70.28

0.11

322

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

246

1.42

1.20

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

197

1709

1.15

1.20

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

164

1.53

1.19

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

194

1683

1.15

1.19

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

630

1.26

1.18

1.0

3.56

0.97

u/ml

0.42

164

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

290

1.38

1.16

1.1

1.2

91.08

78.39

0.92

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

145

1232

1.18

1.16

1.2

93.00

82.51

u/ml

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

0.00

1.15

0.0

1.4

—

0.34

—

(3024471) HLA-A [Type]

439

0.71

1.15

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.72

1.14

1.2

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

118

1.61

1.14

1.6

1.3

22.15

21.94

mmol/l

—

(3000012) Reticulocyte production index

279

2490

1.12

1.13

1.9

2.1

—

(3021788) Differential panel - Synovial fluid

333

3002

1.11

1.12

1.6

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

145

1236

1.17

1.12

1.2

45.00

37.87

u/ml

—

104

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

483

0.72

1.12

2.9

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

115

961

1.20

1.12

1.1

—

(40758292) HTLV I+II Ab panel - Serum

221

0.59

1.11

1.2

1.4

—

(3012441) Differential panel - Pleural fluid

163

1887

0.86

1.11

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

295

2644

1.12

1.11

1.1

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

242

1.41

1.11

1.1

1.4

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.96

1.11

1.0

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

409

3732

1.10

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.95

1.08

1.1

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.96

1.03

1.0

—

(3009015) Lactate [Moles/volume] in Synovial fluid

203

0.59

1.02

1.2

1.3

4.80

6.32

mmol/l

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

483

4458

1.09

1.02

1.9

2.2

92.29

90.59

0.93

467

4263

(3019174) dRVVT (LA screen)

114

1.58

1.02

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.00

1.00

1.1

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

189

1663

1.14

0.99

1.1

—

(3036603) Volume of Urine

125

1067

1.17

0.99

1.3

1.6

2164.61

1851.99

0.85

120

1030

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

209

1854

1.13

0.97

3.0

3.4

5.77

10.38

nmol/l

0.72

200

1799

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

108

1.57

0.96

1.1

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

786

1.20

0.95

2.4

3.3

—

(40757373) Influenza virus identified in Isolate

337

1.31

0.94

1.4

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

304

0.69

0.92

4.1

6.1

—

(40768795) Lymph node Pathology biopsy report

138

1588

0.87

0.92

1.1

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

473

4390

1.08

0.90

1.6

0.40

8.51

iu/ml

1.42

121

993

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

153

1341

1.14

0.88

1.6

1.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

155

0.58

0.88

7.1

5.7

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.65

0.87

1.1

—

3.45

—

(3024932) HLA-DR beta [Type]

427

0.75

0.87

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

156

0.58

0.87

3.6

2.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

202

2256

0.89

0.86

1.7

1.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

322

3512

0.92

0.86

2.4

3.3

388.48

695.64

u/ml

0.80

295

3188

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.78

0.84

1.5

1.3

1.30

1.31

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

113

1308

0.86

0.83

1.1

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

728

7697

0.94

0.83

2.7

3.6

54.79

65.54

u/ml

0.41

691

7413

(3041806) Other cells [#/volume] in Blood by Manual count

240

1.33

0.82

1.4

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

426

1.24

0.81

1.4

1.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

121

1051

1.15

0.81

1.5

1.6

6.89

6.61

u/l

0.09

847

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

555

0.79

0.81

1.3

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

457

4261

1.07

0.80

1.4

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

164

1.40

0.79

1.1

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

396

3675

1.08

0.79

3.4

3.1

0.81

nmol/l

0.13

306

2828

(3047189) Immunofixation for 24 hour Urine

816

0.83

0.78

1.5

1.8

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

173

1.39

0.78

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

132

1158

1.14

0.78

1.1

—

(3022475) Manganese [Moles/volume] in Blood

1.59

0.78

1.0

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

199

1.36

0.77

1.7

1.6

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

143

1263

1.13

0.77

1.4

11.98

13.10

u/l

1.46

137

1214

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.57

0.74

1.5

1.3

440.77

310.75

umol/24h

1.16

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

745

0.83

0.74

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.84

0.73

1.3

1.2

—

mmol/l

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

200

1810

1.11

0.72

2.8

3.8

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

109

0.55

0.72

4.2

4.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

210

1907

1.10

0.71

1.1

118.46

117.52

0.15

198

1689

(3051387) C reactive protein [Mass/volume] in Capillary blood

367

3417

1.08

0.70

4.7

3.5

24.89

28.54

mg/l

1.21

221

2196

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

136

1208

1.13

0.69

1.1

1.2

71.25

163.01

titre

3.41

219

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

116

1020

1.14

0.69

1.2

76.98

90.80

u/l

1.20

882

(40765096) Chromosome analysis panel by Banding

476

0.80

0.69

1.3

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

121

1369

0.88

0.68

2.1

2.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

308

0.75

0.68

1.5

1.9

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

354

3296

1.08

0.68

1.3

241.75

221.13

miu/ml

0.45

134

1418

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.53

0.68

1.2

5.40

0.86

u/ml

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

300

3239

0.92

0.68

1.3

1.4

108.57

173.34

pmol/l

3.69

292

3157

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

676

1.17

0.68

1.2

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

201

1829

1.10

0.67

1.6

1.5

—

(3025130) Human papilloma virus identified in Specimen

175

1583

1.11

0.66

1.9

1.7

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.54

0.65

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.59

0.65

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.61

0.65

1.0

9.12

8.34

mmol/l

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

154

1.36

0.64

2.0

2.5

0.46

1.27

mmol/l

2.80

104

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

116

1026

1.13

0.64

2.5

775.73

643.87

e6/l

2.10

108

981

(3002256) Pathology report gross observation

2115

20603

1.03

0.64

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

504

0.81

0.64

2.0

1.8

18436.00

12515.00

e6/l

0.18

270

(3017704) Immunofixation for Urine

107

942

1.14

0.64

1.3

1.6

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.72

0.64

1.2

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

129

1.40

0.63

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

424

4504

0.94

0.62

6.0

4.4

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

147

1.36

0.61

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

191

1.31

0.60

1.8

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

233

0.73

0.60

1.1

1.2

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.60

0.0

2.8

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

8.91

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

237

2189

1.08

0.59

2.9

2.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

317

1.23

0.59

1.2

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

112

996

1.13

0.59

1.3

1.2

20.80

24.78

u/l

0.35

843

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

151

1367

1.11

0.58

2.2

2.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

778

0.86

0.58

1.2

1.3

1.52

1.56

g/l

0.78

778

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

1.71

0.57

1.0

0.18

0.22

g/l

—

(3036782) Glucose [Moles/volume] in Pleural fluid

151

1664

0.91

0.57

1.3

1.4

5.94

6.35

mmol/l

1.17

139

1529

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

161

0.68

0.56

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

364

0.80

0.56

1.8

1.4

30.41

45.93

g/l

0.45

282

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

356

1.21

0.56

2.0

2.5

7.24

7.88

mmol/l

0.48

219

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

141

1556

0.91

0.55

1.2

1.3

—

(3011648) Oxygen content in Venous blood

133

1201

1.11

0.55

1.9

2.5

11.27

10.85

0.47

133

1201

(43055442) Apixaban [Mass/volume] in Serum or Plasma

257

1.25

0.55

1.6

1.5

122.07

112.83

ug/l

0.22

218

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

147

1335

1.10

0.54

1.4

1.3

1.57

1.42

nmol/l

0.94

133

1200

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

116

1.38

0.54

1.1

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

142

1.34

0.54

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

833

1.13

0.54

3.6

3.7

—

(3041354) Potassium [Moles/volume] in Venous blood

239

2220

1.08

0.54

2.9

2.4

4.08

mmol/l

0.12

239

2199

(3035285) Chloride [Moles/volume] in Venous blood

239

2220

1.08

0.54

2.9

2.4

106.07

105.57

mmol/l

0.87

239

2199

(3020650) Glucose [Presence] in Urine

358

1.20

0.53

1.3

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

478

1.17

0.53

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

302

2831

1.07

0.53

1.6

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

562

1.16

0.53

1.1

95.47

94.79

0.07

429

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

283

0.78

0.53

1.5

5.92

11.40

1.25

146

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

451

1.18

0.52

1.1

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.52

0.52

1.0

1.1

—

20.69

—

(3023199) Leukocytes [#/volume] in Pleural fluid

200

2162

0.92

0.51

1.4

1.5

3554.84

2513.39

e6/l

0.58

147

1559

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.41

0.51

1.1

1.2

527.11

277.76

nmol/l

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

611

1.15

0.51

2.4

2.6

—

(3012565) Volume of 24 hour Urine

809

1.13

0.50

1.9

2.2

2041.79

1895.72

0.60

708

(3014891) Appearance of Pleural fluid

251

1.24

0.50

1.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

215

1.26

0.50

4.2

5.1

48.95

50.33

ug/min

0.04

174

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

615

5892

1.05

0.50

2.7

3.0

0.38

0.35

u/ml

0.81

349

3360

(3032352) Blasts [#/volume] in Cerebral spinal fluid

153

1.31

0.50

1.1

2.1

—

(40762814) Titanium [Mass/volume] in Blood

307

1.21

0.49

2.0

2.2

3.42

3.50

ug/l

0.06

116

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

548

1.15

0.49

1.2

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

128

1.33

0.47

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

452

0.84

0.47

1.4

1.5

—

(4212803) Bone marrow aspirate examination

155

1.29

0.46

1.1

—

(3004775) Volume in Urine collected for unspecified duration

125

1370

0.91

0.46

2.2

584.69

664.50

1.39

909

(3001729) Color of Synovial fluid

138

1.30

0.45

1.3

1.6

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

338

1.18

0.45

1.2

1.86

1.59

mmol/l

0.43

210

(46235168) Fasting glucose [Moles/volume] in Blood

165

1.27

0.44

4.0

2.6

7.94

7.50

mmol/l

0.23

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

283

1.20

0.44

1.7

3.1

126.95

131.06

ng/l

0.04

111

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

116

1059

1.10

0.42

1.6

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

395

4141

0.95

0.42

3.2

1.56

1.63

mg/l

0.84

357

3737

(3020876) Protein [Mass/time] in 24 hour Urine

178

1912

0.93

0.42

2.3

2.5

0.89

1.24

g/24h

1.17

928

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.56

0.42

1.0

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

848

0.90

0.41

2.2

94.63

131.45

ug/min

0.21

198

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

1.36

0.41

1.0

0.06

0.39

u/ml

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.40

0.0

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.39

0.40

1.3

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

184

1969

0.93

0.40

1.4

1.5

80713.33

58799.86

e6/l

0.39

105

1162

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

168

1.25

0.40

1.1

1.0

0.96

5.65

u/ml

0.78

124

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.40

0.0

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.36

0.40

1.2

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

656

0.88

0.39

1.5

1.4

56.42

64.61

1.10

535

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

104

0.67

0.39

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

227

2138

1.06

0.39

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

182

0.77

0.39

1.1

1.2

142.14

104.25

ug/l

—

118

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

353

1.16

0.39

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

752

1.10

0.37

2.9

2.4

205.61

208.62

u/l

0.14

744

(3022689) Creatine [Moles/volume] in Urine

451

0.86

0.37

1.3

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

107

1.31

0.37

2.1

2.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

143

1.26

0.36

2.4

5.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

235

0.81

0.36

1.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

782

1.10

0.36

1.6

1.5

1.47

3.61

2.16

174

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

366

1.15

0.35

1.1

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

1.40

0.35

1.0

1.2

—

(3015183) Erythrocyte sedimentation rate

584

1.11

0.34

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

165

1547

1.07

0.34

1.6

1.5

26.59

29.59

0.52

940

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.37

0.34

1.2

1.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

563

0.89

0.34

1.5

1.4

3.28

2.75

0.18

469

(21494890) Protein electrophoresis panel - 24 hour Urine

192

1811

1.06

0.33

1.6

2.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

209

1.20

0.33

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

209

1.20

0.33

1.3

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

209

1.20

0.33

1.3

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

211

1996

1.06

0.33

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

275

0.84

0.33

1.0

1.2

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

210

1.19

0.32

1.1

44.25

57.26

u/ml

0.52

202

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

370

3850

0.96

0.32

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

119

1106

1.08

0.32

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

436

1.12

0.31

2.8

3.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

101

1.29

0.31

1.0

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

219

2080

1.05

0.31

1.6

1.5

55.48

59.26

0.70

136

1303

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

475

1.12

0.31

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

142

0.77

0.30

2.5

2.0

21.00

61.32

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

100

927

1.08

0.30

1.7

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

203

1.18

0.29

5.0

5.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

239

0.84

0.29

1.3

42.85

342.17

u/l

0.89

171

(3002619) Bacteria identified in Specimen by Culture

344

1.13

0.29

1.4

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

156

1653

0.94

0.29

1.3

359.91

485.16

u/l

1.17

145

1569

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

112

1.25

0.28

1.1

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

158

1.20

0.28

1.3

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

100

1073

0.93

0.27

2.1

1.8

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

346

1.13

0.27

1.4

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

501

0.90

0.27

1.3

57.95

286.79

ug/l

1.73

263

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.23

0.27

1.1

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

113

1059

1.07

0.26

1.2

1.5

2.54

4.35

ug/l

2.09

878

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.21

0.26

1.4

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

924

1.07

0.26

1.7

1.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.19

0.26

1.4

1.7

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

414

1.11

0.26

1.3

36.80

36.44

0.02

278

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

178

1.18

0.26

1.1

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

415

0.89

0.25

1.4

1.6

—

616.20

iu/ml

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.23

0.25

1.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

368

1.11

0.25

1.8

1.9

9.18

9.26

mg/l

0.04

297

(3001556) Androgen free Index in Serum or Plasma

1.18

0.24

1.6

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

148

0.81

0.24

4.3

2.8

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

507

0.91

0.24

2.2

1.9

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

369

1.11

0.24

2.5

3.1

7.15

7.51

mg/l

0.14

301

(3026470) Cobalt [Mass/volume] in Blood

104

1106

0.94

0.24

2.0

1.9

3.74

3.65

ug/l

0.05

1009

(3035880) pH of Pleural fluid

992

0.94

0.23

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

199

1.16

0.23

1.1

—

(3008607) Semen analysis panel

1.25

0.22

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.25

0.22

4.6

3.6

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.74

0.22

1.3

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

166

1586

1.05

0.22

1.1

2.47

1.96

iu/ml

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

152

1449

1.05

0.22

1.1

95.30

94.84

0.09

146

1340

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.22

0.22

5.0

9.6

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.21

0.0

1.2

—

38.09

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.21

0.0

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.21

0.0

7.6

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.21

0.0

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.21

0.0

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.21

0.0

1.0

—

164.17

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.21

0.0

1.8

—

9.77

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

450

1.09

0.20

1.1

—

(3025577) Chromium [Mass/volume] in Blood

102

1078

0.95

0.20

2.0

2.28

2.31

ug/l

0.03

901

(3042631) Mycobacterium sp identified in Specimen

229

2373

0.96

0.20

2.6

2.7

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

117

1.20

0.20

1.4

1.7

0.77

0.63

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.20

0.0

1.0

—

(3042733) HLA Ab [Presence] in Serum

428

0.91

0.20

5.4

5.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

635

0.93

0.20

31.1

26.9

110.19

111.85

ug/l

0.06

528

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

497

4857

1.02

0.20

1.9

1.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

520

1.08

0.19

2.1

1.8

13900.00

47045.27

u/ml

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

109

1.19

0.18

1.1

1.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

109

1.19

0.18

1.1

1.0

0.40

0.15

u/ml

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

930

1.05

0.18

6.3

6.4

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.15

0.17

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1050

10358

1.01

0.17

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

115

1202

0.96

0.16

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

309

0.91

0.16

1.0

1.8

2.51

2.32

ug/l

0.10

176

(3011325) HIV 1+2 Ab [Presence] in Serum

0.71

0.16

1.4

1.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

836

1.05

0.16

1.6

1.8

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

130

0.85

0.16

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

312

1.09

0.15

1.3

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

149

1.14

0.15

1.8

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

297

3043

0.98

0.15

5.1

5.2

1556.74

1602.13

iu/ml

0.02

461

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

182

0.88

0.15

1.3

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

667

0.94

0.15

1.7

2.0

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

228

2344

0.97

0.15

2.6

2.5

376.10

5647.66

u/ml

—

145

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.11

0.15

1.2

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

127

1318

0.96

0.14

2.1

1.8

3.54

4.18

mg/l

1.52

118

1247

(3006462) Nitrate [Presence] in Urine

788

0.95

0.14

3.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

103

1.17

0.13

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

132

1.14

0.13

1.1

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

481

1.06

0.13

1.3

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

355

0.93

0.12

2.2

2.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

148

0.88

0.12

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

104

1.15

0.12

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

162

1666

0.97

0.12

1.4

1.5

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

261

0.92

0.11

1.2

1.3

0.91

1.26

mmol/l

0.22

169

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

127

1309

0.97

0.11

1.3

13.06

13.94

u/l

0.32

115

1203

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

842

0.96

0.11

2.7

41.49

38.58

0.84

488

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

838

1.04

0.11

1.6

1.8

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.16

0.11

1.5

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

260

0.92

0.10

1.4

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

363

3686

0.98

0.10

1.5

—

(37019676) Renin [Units/volume] in Plasma --supine

1.09

0.09

1.0

1.1

110.34

56.10

mu/l

—

(21494814) CD8 cells/100 lymphocytes in Specimen

596

1.04

0.09

2.0

—

(3000034) Microalbumin [Mass/volume] in Urine

145

1483

0.98

0.08

3.0

24.25

44.83

mg/l

1.49

106

1069

(3010937) Rubella virus Ab [Presence] in Serum

0.82

0.08

1.4

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

226

0.93

0.08

1.8

1.6

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.08

0.08

1.3

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

338

0.95

0.08

1.2

1.3

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.06

0.08

1.0

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

274

2780

0.99

0.07

1.4

1.5

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.86

0.07

3.3

3.4

—

0.00

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.12

0.07

1.1

1.33

1.05

u/field

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.04

0.07

1.1

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

104

0.87

0.06

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

354

3576

0.99

0.06

4.3

3.4

7.22

7.65

mmol/l

2.61

349

3501

(3029396) Erythrocyte agglutination [Presence] in Blood

223

0.94

0.06

2.2

2.7

—

(3016750) Collection duration of Urine

981

0.98

0.06

2.2

2.1

495.65

500.26

min

0.15

715

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

657

0.97

0.05

1.6

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

657

0.97

0.05

1.6

2.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

663

1.03

0.05

1.1

4.3

78.10

759.08

mg/l

0.81

463

(3032868) Hemoglobin electrophoresis panel in Blood

110

1.09

0.05

1.3

1.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

160

0.94

0.04

1.3

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

119

0.92

0.03

3.1

2.6

—

(40768446) Kidney Pathology biopsy report

557

1.02

0.03

1.7

1.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

319

1.03

0.03

1.0

—

(3004809) Band form neutrophils/100 leukocytes in Blood

272

2741

0.99

0.03

2.4

3.4

1.62

1.57

0.07

233

2418

(3046861) Legionella sp Ag [Presence] in Urine

1.09

0.03

1.4

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

551

0.98

0.03

1.3

4.33

3.30

mmol/l

1.33

507

(44786800) Granulocytes/100 leukocytes in Body fluid

239

0.96

0.02

1.3

43.78

22.75

1.30

185

(3005082) Progesterone [Moles/volume] in Serum or Plasma

410

1.02

0.02

1.3

1.4

27.48

31.29

nmol/l

0.46

356

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

401

1.02

0.02

1.9

1.5

8.46

9.01

ug/l

0.49

401

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

208

0.96

0.02

1.8

1.9

—

(21494434) Karyotype in Bone marrow

142

1408

1.01

0.02

1.2

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

760

0.99

0.02

1.3

5.77

5.94

mmol/l

0.91

721

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

232

1.03

0.02

10.9

10.8

7.18

5.40

mmol/l

0.80

232

(3034426) Prothrombin time (PT)

471

1.02

0.02

1.1

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

173

1.04

0.01

1.1

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

155

1541

1.01

0.01

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

215

2159

1.00

0.01

1.9

22.22

22.65

ug/l

0.04

209

2101

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

126

0.95

0.00

1.2

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

346

0.98

0.00

4.4

1.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

586

0.99

0.00

38.3

33.3

6.76

7.25

ug/l

1.52

521

(3034092) Cytoplasmic Ig cells/100 cells in Blood

174

0.98

0.00

9.7

8.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

545

0.99

0.00

1.3

38.20

39.86

g/l

0.26

283

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

104

0.96

0.00

1.0

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

848

1.00

0.00

1.1

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

440

1.00

0.00

1.1

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

570

1.00

0.00

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

350

1.00

0.00

1.3

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

465

0.99

0.00

2.0

1.8

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

611

1.00

0.00

1.6

1.5

8.16

8.17

mmol/l

0.01

582

(3048879) Bone marrow aspiration report

512

1.00

0.00

1.3

1.8

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

171

1709

1.00

0.00

2.4

3.4

60.63

56.92

1.61

140

1431

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

124

1235

1.00

0.00

1.7

1.6

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.93

0.00

5.3

3.3

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.2

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.87

-0.00

1.0

2.3

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.97

-0.00

15.7

8.6

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.4

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(36304079) Mucus [Presence] in Urine sediment

0.00

-0.00

0.0

1.1

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.3

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(40758358) Immune stain study

0.99

-0.00

1.0

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.00

-0.00

1.2

1.27

1.90

mg/l

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_XTRAPYR and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_XTRAPYR	1.71 [1.58, 1.85]	< 0.001
Birth year	0.993 [0.98, 1.0]	0.077

During the follow-up period (1.1.1998 — 31.12.2019), 15474 out of 49855 females with G6_XTRAPYR died.

Males

Parameter	HR [95% CI]	p-value
G6_XTRAPYR	1.859 [1.69, 2.04]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 17700 out of 44915 males with G6_XTRAPYR died.

Mortality risk

Mortality risk for people of age

years, who have G6_XTRAPYR.

N-year risk	Females	Males
1	0.202%	0.363%
5	0.939%	2.201%
10	2.404%	5.279%
15	4.468%	9.637%
20	7.572%	15.859%

Relationships between endpoints

↥

Index endpoint: G6_XTRAPYR – Extrapyramidal and movement disorders

GWS hits: 7

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Extrapyramidal and movement disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints